homocysteine has been researched along with Coronary Disease in 485 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (1.24) | 18.7374 |
1990's | 154 (31.75) | 18.2507 |
2000's | 278 (57.32) | 29.6817 |
2010's | 38 (7.84) | 24.3611 |
2020's | 9 (1.86) | 2.80 |
Authors | Studies |
---|---|
Chen, Z; Fan, L; Gao, BH; Li, Q; Yuan, XF; Zhang, B; Zhang, L | 1 |
Hua, N; Liu, C; Wang, C; Zhang, Y | 1 |
Broncel, M; Chałubiński, M; Chmiela, M; Gonciarz, W; Kaca, W; Lechowicz, Ł; Rechciński, T; Urbaniak, M | 1 |
Guo, H; He, M; Jiang, J; Long, P; Mo, T; Niu, R; Peng, R; Shi, L; Wang, Q; Wang, Y; Wu, T; Xu, C; Yang, H; Zhang, X | 1 |
Cai, X; Li, N; Luo, Q; Ren, Y; Wang, G; Wang, M; Yao, L; Yue, N; Zhao, J | 1 |
Bai, L; Du, Y; Han, K; Lu, Q; Wang, TZ; Zhu, WJ | 1 |
Du, B; Huang, X; Li, D; Ren, B; Yue, L; Zhang, C; Zhang, W; Zhao, Q | 1 |
Jiang, Y; Shi, Y; Xu, H; Yu, K; Zhang, G; Zhang, X | 1 |
Guan, J; Pan, L; Wu, L; Xiao, Q | 1 |
Elsamanoudy, AZ; Gaballah, MA; Saafan, FA; Shaalan, D; Zeidan, N | 1 |
Li, L; Liu, H; Liu, J; Shang, G; Wang, H; Zhao, H; Zhou, Y | 1 |
Cui, BB; Fu, RL; Geng, HH; Jin, YP; Li, B; Wang, JJ; Wang, PX; Wang, Q; Zhang, Q | 1 |
Chen, Z; Dong, Y; Kang, Y; Shao, L; Tian, Y; Wang, J; Wang, X; Wang, Z; Zhang, L; Zheng, C | 1 |
Guo, R; Jin, Z; Ma, J; Sun, C; Yan, P; Yang, B | 1 |
Fang, S; Wu, J; Zhou, C | 1 |
Berg, C; Björck, L; Blennow, K; de Faire, U; Leander, K; Lissner, L; Mehlig, K; Nyberg, F; Rosengren, A; Strandhagen, E; Thelle, D; Tognon, G; Torén, K; Zetterberg, H | 1 |
Aizawa, T; Funase, Y; Ouchi, K; Sato, Y; Yamauchi, K | 1 |
Assendelft, WJ; Blom, HJ; Blom, JW; de Craen, AJ; de Ruijter, W; Drewes, YM; Ford, I; Gussekloo, J; Poortvliet, RK; Sattar, N; Stott, DJ; Westendorp, RG; Wouter Jukema, J | 1 |
Ebadi, M; Esteghamati, A; Hafezi-Nejad, N; Nakhjavani, M; Sheikhbahaei, S; Zandieh, A | 1 |
Agarwal, I; Bertoia, ML; Cahill, LE; Jensen, MK; Mukamal, KJ; Rimm, EB | 1 |
Chen, Y; Hong, C; Riley, RD | 1 |
Fan, Y; Man, CF; Peng, HY; Xu, J | 1 |
Jensen, MK; Kraft, P; Mukamal, KJ; Pai, JK; Pers, TH; Rimm, EB | 1 |
Chen, S; Chen, Z; Duan, S; Fan, R; Han, L; Hao, Y; Li, R; Liu, S; Liu, Y; Ma, J; Peng, X; Wang, C; Wu, Q; Zhang, L; Zhang, T; Zhao, J | 1 |
Chen, S; Chen, Z; Han, L; Liu, S; Ma, J; Peng, X; Wang, C; Zhao, D | 1 |
Feng, L; Nian, S; Xu, W; Ye, D; Zhang, S; Zhang, X; Zheng, L | 1 |
Chen, S; Chen, Y; Guo, X; Qian, H; Sun, G; Sun, Y; Zhang, N | 1 |
Aldámiz-Echevarría, L; Couce, ML; Fernández-Marmiesse, A; Hermida, A; Leis, R; Llarena, M; Roca, I; Sánchez-Pintos, P; Vitoria, I | 1 |
Ariogul, S; Aytemir, K; Barak, A; Cankurtaran, M; Dede, DS; Halil, M; Kabakci, G; Karabulut, E; Oto, A; Ulger, Z; Yavuz, B; Yavuz, BB | 1 |
Bayraktar, N; Esinler, I; Kulaksizoglu, S; Oktem, M; Ozcimen, EE; Pamuk, B; Uckuyu, A; Zeyneloglu, HB | 1 |
Ayhan, E; Bulur, S; Can, G; Hergenç, G; Küçükdurmaz, Z; Onat, A | 1 |
Fuchs, D; Mark, M; Reinhart, WH; Schroecksnadel, K; Walter, RB; Weiss, G | 1 |
Freeman, M; Fu, R; Helfand, M; Humphrey, LL; Rogers, K | 1 |
Lavie, CJ; Milani, RV | 1 |
Bray, P; Cushman, M; Greenland, P; Hendrix, S; Hsia, J; Kooperberg, C; Lloyd-Jones, DM; Pettinger, M; Robinson, J; Rossouw, JE | 1 |
Kaptanoğlu, B; Ozdemir, A; Ozdemir, O; Rota, S; Semiz, S | 1 |
Nagalla, B; Pitla, S | 1 |
Cheng, X; Luo, D; Song, Y; Yan, S | 1 |
Chen, MF; Dahhou, M; Dassa, C; Evans, R; Genest, J; Goulet, L; Kahn, SR; Kramer, MS; Lydon, J; McNamara, H; Platt, RW; Rozen, R; Séguin, L | 1 |
Chellappa, P; Ramaraj, R | 1 |
Md Nurul Jain, J; Prasad Chintakindi, K; Rama Devi Akella, R; Shaik Mohammad, N; Vinukonda, G | 1 |
Hoogeveen, EK; Stehouwer, CD | 2 |
Givvimani, S; Maldonado, C; Pushpakumar, S; Rosenberger, D; Soni, CV; Todnem, ND; Tyagi, SC; Villafane, J | 1 |
Chen, MF; Chien, KL; Hsu, HC; Lee, YT; Su, TC; Sun, Y | 1 |
Eshraghian, A; Izadi, HR; Naghshvar, F; Pourahmad, M; Shojaie, M | 1 |
Lennie, TA; Son, YJ; Song, EK | 1 |
Mitka, M | 1 |
Burdan, F; Dworzański, W; Opielak, G | 1 |
Aybay, C; Biberoğlu, G; Ezgü, F; Hasanoglu, A; Ozbay, F; Tümer, L | 1 |
D'Agostino, R; Jacques, P; O'Donnell, CJ; Pencina, M; Selhub, J; Wilson, PW | 1 |
Halilovic, E; Kabil, E | 1 |
Drygas, W; Jasiński, B; Kozakiewicz, K; Pajak, A; Posadzy-Małaczyńska, A; Rywik, S; Tykarski, A; Wyrzykowski, B | 1 |
Dent, TH | 1 |
Didelez, V; Meng, S; Sheehan, NA | 1 |
Garg, A | 1 |
Clarke, R | 2 |
Gong, SJ; Hu, BC; Li, L; Yan, J | 1 |
Chen, L; Cheng, X; Hong, K; Hu, J; Liu, L | 1 |
Prabhakaran, D; Singh, K | 1 |
Agrawal, A; Gupta, BK; Gupta, R; Khatri, M; Panwar, RB; Raja, S; Vaishnav, J | 1 |
Flood, VM; Gopinath, B; Mitchell, P; Rochtchina, E; Thiagalingam, A | 1 |
Pan, F; Pan, Y; Tian, J; Zhang, Y | 1 |
Anand, SS; Assimes, TL; Bennett, DA; Chambers, JC; Clarke, R; Collins, R; Danesh, J; Dötsch-Klerk, M; Elbers, C; Engert, JC; Holm, H; Hopewell, JC; Kleber, ME; Kooner, J; Lathrop, M; Nordestgaard, BG; Ouwehand, WH; Parish, S; Peters, B; Peto, R; Reilly, MM; Saleheen, D; Samani, NJ; Stewart, AF; Tanaka, T; Thorand, B; Verhoef, P; Watkins, H; Xu, P; Yamada, Y; Yusuf, S | 1 |
Loscalzo, J; Ueland, PM | 1 |
Chen, Y; Huang, T; Li, D; Wahlqvist, ML; Yang, B; Yang, J | 1 |
Incampa, S; Jaiyen, S; Khaithong, W; Saokaew, S; Sridetch, S; Sudchada, P | 1 |
Gjessing, HK; Igland, J; Nygård, OK; Tell, GS; Ueland, PM; Vollset, SE | 1 |
Markovic, D; Ovbiagele, B; Towfighi, A | 1 |
Baudin, B; Chalghoum, A; Chkioua, L; Dandana, A; Ferchichi, S; Gammoudi, I; Jeridi, G; Khelil, S; Miled, A; Noichri, Y | 1 |
Huang, T; Li, D | 1 |
Connelly, PW; Cunnane, SC; Faulkner, D; Jackson, CJ; Jenkins, DJ; Josse, RG; Kendall, CW; Leiter, LA; Parker, T; Vidgen, E | 1 |
Kareinen, A; Laakso, M; Lehto, S; Nieminen, MS; Pajunen, P; Syvänne, M; Viitanen, L | 1 |
Abdella, N; Akanji, AO; Al Mohammedi, H; Mojiminiyi, OA; Moussa, MA; Zaki, M | 1 |
Ashavaid, TF; Dalal, JJ; Eghlim, FF; Nair, KG; Nair, SR | 1 |
Andersson, A; Hultberg, B; Jonasson, T; Lindgren, A; Ohlin, H | 1 |
Connelly, PW; Faulkner, D; Haight, JS; Jenkins, DJ; Kendall, CW; Lapsley, KG; Marchie, A; Parker, TL; Qian, W; Spiller, GA; Vidgen, E | 1 |
Fini, M; Galetta, P; Mercuro, G; Rosano, GM; Rossini, P; Vitale, C | 1 |
Bös, U; Pabst, E; Semmelrock, HJ; Stanger, O; Wascher, TC; Wonisch, W | 1 |
Elisaf, M | 1 |
Robinson, K | 1 |
Mehta, JL; Saldeen, TG | 1 |
Wnuk, SF | 1 |
MacMahon, S; Neal, B; Ohkubo, T; Tonkin, A; Wilcken, D | 1 |
McLaughlin, MA; Nguyen, VH | 1 |
Ballman, KV; Berger, PB; Brilakis, ES; Klee, GG; McConnell, JP | 1 |
Elovaara, I; Jaakkola, O; Janatuinen, T; Jokela, H; Knuuti, J; Laakso, J; Laaksonen, R; Lehtimäki, T; Nuutila, P; Punnonen, K; Raitakari, O; Saikku, P; Salminen, K; Vesalainen, R | 1 |
Angelini, GD; Ascione, R; Day, A; Jeremy, JY; Shukla, N; Talpahewa, SP; Wan, IY | 1 |
El-Hazmi, MA | 1 |
Caldera, A; Dec, GW | 1 |
Tonstad, S; Urdal, P | 1 |
Blom, HJ; de Graaf, J; den Heijer, M; Stalenhoef, AF; Veerkamp, MJ | 1 |
Herrmann, W; Jouma, M; Obeid, R | 1 |
Abdella, NA; Akanji, AO; Mojiminiyi, OA; Moussa, MA | 1 |
Guo, JX; Wang, X; Zhang, Q | 1 |
Blom, HJ; de Bree, A; Kromhout, D; Nadeau, M; Trijbels, FJ; Verschuren, WM | 1 |
Blom, HJ; De Bree, A; Kromhout, D; Mennen, LI; Verschuren, WM | 1 |
Brnabic, A; MacMahon, S; Neal, B; Ohkubo, T; Tonkin, A | 1 |
Busch, M; Franke, S; Kientsch-Engel, R; Müller, A; Sommer, M; Stein, G | 1 |
Adler, Y; Behar, S; Boyko, V; Brunner, D; Doolman, R; Goldbourt, U; Haim, M; Sela, BA; Tanne, D | 1 |
Cheek, DJ; Coffey, M; Crowder, GK | 1 |
Haynes, WG | 1 |
Elliott, KM | 1 |
Law, M; Morris, J; Wald, DS; Wald, NJ | 1 |
Handy, DE; Loscalzo, J | 1 |
Acevedo, M; Jacobsen, DW; Minor, S; Pearce, GL; Sprecher, DL | 1 |
Blom, HJ; den Heijer, M; Klerk, M; Kluijtmans, LA; Kok, FJ; Lievers, KJ; Schouten, EG; Verhoef, P | 1 |
Berg, K; Eikvar, L; Retterstol, L | 1 |
Baumgartner, RN; Garry, PJ; Lindeman, RD; Romero, LJ; Schade, DS; Wayne, S | 1 |
Essebag, V; Genest, J; Pilote, L; Suissa, S | 1 |
Chen, C; Conklin, BS; Fu, W; Lin, PH; Lumsden, AB; Yao, Q | 1 |
Akdemir, I; Aksoy, M; Aksoy, N; Davutoglu, V; Dinckal, MH; Dinckal, N; Kirilmaz, A; Soydinc, S | 1 |
Bruce, IN; Gladman, DD; Ibañez, D; Steiner, G; Urowitz, MB | 1 |
Derbeneva, SA; Pogozheva, AV | 1 |
Aranda, JL; Díaz-Rubio, P; Fernández-Miranda, C; Gómez de la Cámara, A; Gómez, P; Martínez, J; Núñez, V; Paz, M | 1 |
Law, M; Morris, J; Wald, DS | 1 |
Doshi, S; Goodfellow, J; Lewis, M; McDowell, I; Moat, S | 1 |
Geisel, J; Hennen, B; Herrmann, W; Hübner, U; Knapp, JP | 1 |
Clement, L | 1 |
Chen, J; Hamm, LL; He, J; Kusek, JW; Muntner, P; Whelton, PK | 1 |
Demant, T | 1 |
Anderson, JL; Bair, TL; Carlquist, JF; Horne, BD; Jensen, KR; Muhlestein, JB | 1 |
Chambless, LE; Howard, VJ; Malinow, MR; Pettigrew, LC; Sides, EG; Spence, JD; Stampfer, M; Toole, JF; Wang, CH | 1 |
Bengtsson, C; Björkelund, C; Landaas, S; Lissner, L; Sundh, V; Thelle, D; Zylberstein, DE | 1 |
Huffman, FG; Koutoubi, S | 2 |
Adamidis, DN; Boufidou, AI; Gourassas, JT; Karvounis, HI; Kesidis, HT; Louridas, GE; Makedou, AD; Makedou, KG; Papadopoulos, CE; Parharidis, GE | 1 |
Beevers, GD; Blann, AD; Felmeden, DC; Lip, GY; Martin, SC; Spencer, CG | 1 |
Liebson, PR | 1 |
Bisschops, RH; Mali, WP; van der Graaf, Y; van der Grond, J | 1 |
Abalain, JH; Lacut, K; Moineau, MP; Mottier, D; Oger, E | 1 |
Holubec, L; Mayer, O; Pikner, R; Simon, J; Trefil, L; Vobrubová, I | 1 |
Demacker, PN | 1 |
Erglis, A; Fuchs, D; Jegere, S; Jurika, E; Kalnins, U; Rudzite, V; Silava, A; Trusinskis, K | 1 |
Doshi, SN; Goodfellow, J; Lang, D; Lewis, MJ; McDowell, IF; Moat, SJ | 1 |
Börner, C; Dambrink, JH; De Luca, G; Dille, J; Kallmayer, K; Lange, H; Pasalary, MN; Scherer, E; Suryapranata, H | 1 |
Hayashida, Y; Morishita, T; Nakashima, Y; Nakata, S; Sasaguri, Y; Suda, O; Tasaki, H; Toyohira, Y; Tsujimoto, T; Tsutsui, M; Ueno, S; Ueta, Y; Yanagihara, N | 1 |
Wilson, PW | 1 |
Alfthan, G; Kaplan, GA; Laukkanen, J; Mursu, J; Nyyssönen, K; Rissanen, TH; Salonen, JT; Tuomainen, TP; Valkonen, VP; Virtanen, JK; Voutilainen, S | 1 |
Nishio, I; Tsuda, K | 1 |
Christodoulou, G; Chrysohoou, C; Panagiotakos, DB; Papageorgiou, C; Pitsavos, C; Stefanadis, C; Tsetsekou, E | 1 |
Moleerergpoom, W; Sritara, P; Sura, T | 1 |
Divitini, ML; Knuiman, MW; O'Leary, CM | 1 |
Larson, L; Léger, MM; McNellis, R; Quigley, T; Toth, S; Van Dyke, E | 1 |
Abrams, KR; Minelli, C; Thompson, JR; Tobin, MD | 1 |
Herer, P; Luboshitzky, R | 1 |
Fowler, B; Herrmann, W; Stanger, O | 1 |
Roth, E; Szabo, T; Szamosi, T; Tomsits, E; Tordai, A | 1 |
Bruckert, E; Jublanc, C | 1 |
Dobordzhginidze, LM | 1 |
Curhan, G; Hankinson, SE; Ma, J; Manson, JE; Rifai, N; Rimm, EB; Shai, I; Stampfer, MJ | 1 |
Guo, JX; Hou, LF; Wang, X; Wang, Z; Zhao, YM | 1 |
Helenius, H; Juonala, M; Laitinen, T; Marniemi, J; Raitakari, OT; Rönnemaa, T; Viikari, JS | 1 |
Cannuscio, C; Curhan, G; Hankinson, SE; Ma, J; Manson, JE; Rimm, EB; Selhub, J; Shai, I; Stampfer, MJ | 1 |
Harringer, W; Haverich, A; Kutschka, I; Pethig, K; Strüber, M | 1 |
Mao, JM; Wang, G; Wang, X; Zhang, FC | 1 |
Lu, H; Sun, J; Xu, Y; Xue, J; Zhu, Y | 1 |
Abbate, R; Brunelli, T; Falai, M; Fedi, S; Gensini, GF; Giusti, B; Gori, AM; Marcucci, R; Margheri, M; Pepe, G; Prisco, D | 1 |
Geisel, J; Herrmann, W; Hübner, U; Jouma, M; Obeid, R | 1 |
Charvát, J; Chlumský, J; Kvapil, M; Michalová, K; Táborská, K; Vojácek, J | 1 |
Magkos, F; Manios, Y; Matalas, AL; Papaconstantinou, E; Papoutsakis, C; Schulpis, KH; Yiannakouris, N; Zampelas, A | 1 |
Bodi, V; Chorro, FJ; Fácila, L; G, VB; Llacer, A; Nuñez, JE; Sanchis, J | 1 |
Akdemir, R; Arinc, H; Binak, E; Gunduz, H; Ozhan, H; Tamer, A; Uyan, C | 1 |
Cesari, M; Pessina, AC; Rossi, GP; Sticchi, D | 1 |
Abrams, KR; Minelli, C; Riley, RD; Thompson, JR; Tobin, MD | 1 |
Bickel, C; Blankenberg, S; Cambien, F; Espinola-Klein, C; Lackner, KJ; Lubos, E; Münzel, T; Rupprecht, HJ; Schnabel, R; Tiret, L; Torzewski, M | 1 |
Aziz, DC; Blumenthal, RS; Budoff, MJ; Nasir, K; Park, R; Rasouli, ML | 1 |
Naidoo, D; Salonikas, C; Sim, AS; Wang, J; Wang, XL; Wilcken, DE | 1 |
Hendrix, SL; LaCroix, AZ; Langer, RD; Lewis, CE; Manson, JE; Pradhan, AD; Ridker, PM; Rossouw, JE | 1 |
Abbate, R; Brogi, D; Gensini, GF; Giglioli, C; Gori, AM; Lenti, M; Liotta, AA; Marcucci, R; Prisco, D; Sofi, F; Valente, S | 1 |
Favilla, S; Ghiadoni, L; Pinto, S; Salvetti, A; Salvetti, G; Taddei, S; Versari, D; Virdis, A | 1 |
Boeing, H; Dierkes, J; Hoffmann, K; Jung, R; Klipstein-Grobusch, K; Schulze, MB; Weikert, C; Windler, E; Zyriax, BC | 1 |
Chen, Z; Gao, Y; Hui, R; Liu, Y; Song, L; Wang, J; Xu, H; Yang, X; Yang, Y; Zhen, Y; Zhou, J | 1 |
Garcés Pasamontes, A; Morón de Salim, AR | 1 |
Chillemi, R; D'Agata, A; Minucci, A; Musumeci, S; Persichilli, S; Simpore, J | 1 |
Clarke, R; Lewington, S | 1 |
Cesari, M; Pessina, AC; Rossi, GP | 1 |
Göller, V | 1 |
Ekerbicer, H; Guven, A; Inanc, F; Kilinc, M | 1 |
Boran, G; Enright, H; Fitzgerald, A; Fogarty, J; Gaffney, P; Graham, IM; Hanbidge, M; McCarthy, B; Murphy, J; O'Callaghan, PA | 1 |
Sakuta, H; Suzuki, T | 1 |
Aksoy, Y; Turhan, H; Yetkin, E | 1 |
Aksoy, Y; Kosar, F; Ozerol, I; Sincer, I | 1 |
Chau, WK; Gau, JP; Ho, CH; Hsu, HC; Kong, CW; Kuo, BI; Yu, YB | 1 |
Dowey, le RC; Dunne, A; Hannon-Fletcher, M; Hughes, JP; McAnena, LB; McNulty, H; Molloy, AM; Scott, JM; Strain, JJ; Ward, M | 1 |
Alatas, O; Dinleyici, EC; Dogruel, N; Kilic, Z; Kirel, B; Muslumanoglu, H | 1 |
Bailey, KR; Bielak, LF; Kardia, SL; Kullo, IJ; Li, G; Peyser, PA; Sheedy, PF; Turner, ST | 1 |
Happonen, P; Lakka, TA; Laukkanen, JA; Mursu, J; Poulsen, H; Rissanen, TH; Salonen, JT; Virtanen, JK; Voutilainen, S | 1 |
Baumgart, D; Beckert, J; Breuckmann, F; Erbel, R; Haude, M; Naber, C; Schmermund, A | 1 |
Abramson, JH; Adler, B; Calderon-Margalit, R; Gofin, J; Kark, JD | 1 |
Armstrong, KA; Isbel, NM; Johnson, DW; Leano, R; Marwick, TH; Rakhit, DJ | 1 |
Best, JD; Clemens, L; Dragicevic, G; Godfrey, T; Jenkins, AJ; Karschimkus, CS; Lee, AB; Nikpour, M; Prior, DL; Romas, E; Rowley, KG; Wilson, AM | 1 |
Behar, S; Boyko, V; Brunner, D; Doolman, R; Goldbourt, U; Haim, M; Sela, BA; Tanne, D | 1 |
Amouyel, P; Arveiler, D; Ducimetière, P; Evans, A; Ferrières, J; Kee, F; Patterson, CC; Troughton, JA; Woodside, JV; Yarnell, JW; Young, IS | 1 |
Elmadfa, I; Genser, D; Halbmayer, WM; Hauer, R; Mlczoch, J; Prachar, H | 2 |
Chernikova, IV; Kostiuchenko, GI; Kostiuchenko, LA; Kulikov, VP | 1 |
Bolaman, Z; Kadikoylu, G; Ozgel, N; Yenisey, C | 1 |
Hajer, GR; Olijhoek, JK; van der Graaf, Y; Verhaar, MC; Visseren, FL | 1 |
Dudczak, R; Graf, S; Huber, K; Khorsand, A; Kletter, K; Maurer, G; Nekolla, S; Nikfardjam, M; Ofluoglu, S; Pirich, C | 1 |
Cui, RZ; Li, Y; Li, YL; Qin, Q; Wang, H; Zhao, BR; Zhao, FM | 1 |
Li, J; Li, JJ; Li, Z | 1 |
Bilsel, T; Cakmak, N; Ciloglu, F; Erdem, I; Orhan, L; Peker, I; Sayar, N; Tangurek, B; Terzi, S; Yesilcimen, K; Yilmaz, HY | 1 |
Alfthan, G; Erlund, I; Happonen, P; Kaplan, GA; Kauhanen, J; Korhonen, M; Mosher, MJ; Mursu, J; North, KE; Salonen, JT; Tiihonen, J; Tuomainen, TP; Virtanen, JK; Voutilainen, S | 1 |
Filipovský, J; Mayer, O; Pikner, R; Plásková, M; Simon, J | 1 |
Mair, J | 1 |
Boev, M; Doncheva, N; Niagolov, Y; Penkov, A; Popov, B; Velcheva, A | 1 |
Adamopoulou, EN; Argyrakis, SK; Beldekos, DJ; Foussas, SG; Handanis, SM; Hatzisavvas, JJ; Makrygiannis, SS; Manolis, AJ; Manousakis, SJ; Melidonis, AI; Patsourakos, NG; Zairis, MN | 1 |
Domagała, TB; Jakubowski, H; Mackness, B; Mackness, MI; Trzeciak, WH; Łacinski, M | 1 |
Greany, KA; Kurzer, MS; Nettleton, JA; Thomas, W; Wangen, KE | 1 |
das Graças Carvalho, M; de Castro Santos, ME; Dusse, LM; Fernandes, AP; Lima, LM; Mota, AP; Ribeiro, DD; Sabino, A; Sousa, MO | 1 |
Cui, R; Date, C; Iso, H; Kikuchi, S; Koike, KA; Moriyama, Y; Tamakoshi, A | 1 |
Hasić, S; Jadrić, R; Kiseljaković, E; Resić, H; Skenderi, F; Winterhalter-Jadrić, M | 1 |
Gupta, VJ; Reddy, SG; Wilcken, DE | 1 |
Bostom, AG; Ellison, RC; Jacques, PF; Nadeau, MR; Selhub, J; Williams, RR | 1 |
Adão, M; Azinheira, J; Bordalo e Sá, AL; Ferreira, NC; Luís, AS; Pina, JE; Reis, HP; Reis, RP; Santos, L; Vilaverde, MM | 1 |
Beresford, SA; Boushey, CJ; Motulsky, AG; Omenn, GS | 1 |
Becker, PJ; Delport, R; Potgieter, H; Ubbink, JB; van der Merwe, A; Vermaak, WJ | 1 |
Graham, IM; Meleady, RA | 1 |
Becker, PJ; Delport, R; Ubbink, JB; Vermaak, WJ | 1 |
Berwanger, CS; Jeremy, JY; Stansby, G | 1 |
Hopkins, PN; Hunt, SC; James, BC; Vincent, GM; Williams, RR; Wu, J; Wu, LL | 2 |
Bostom, AG; Eaton, CB; Hume, AL; Jacques, PF; McQuade, W; Nadeau, M; Perrone, G; Selhub, J; Yanek, L | 1 |
Dalery, K; Davignon, J; Genest, J; Latour, Y; Lussier-Cacan, S; Selhub, J | 1 |
Glueck, CJ; Lang, JE; Shaw, P; Sieve-Smith, L; Tracy, T; Wang, Y | 1 |
Malinow, MR | 2 |
Ubbink, JB | 3 |
Ascherio, A; Willett, WC | 1 |
Abdelnoor, M; Arnesen, H; Berg, K; Eritsland, J; Grønseth, K; Malinow, MR; Seljeflot, I | 1 |
Ambrosi, P; Barlatier, A; Garcon, D; Habib, G; Kreitman, B; Luccioni, R; Metras, D; Roland, PH; Saingra, S | 1 |
Boers, GH | 1 |
Assmann, G; Heinrich, J; Köhler, E; Malinow, MR; Schönfeld, R; Schulte, H; Upson, B; von Eckardstein, A | 1 |
Acton, RT; Alvarez, JO; Copeland, RB; Cousins, AL; Go, RC; Lewis, CA; Macaluso, M; Pancharuniti, N; Perkins, LL; Sauberlich, HE | 1 |
Alderman, EL; Murphy-Chutorian, D | 1 |
Daly, L; Graham, IM; Robinson, K; Tan, KS | 1 |
Bostom, AG; Catalfamo, J; Eaton, CB; McQuade, W; Selhub, J; Yanek, L | 1 |
Dudman, NP; Lundberg, P; Lynch, JF; Macey, D; Wang, J; Wilcken, DE | 1 |
Bierdrager, E; Rauwerda, JA; Stehouwer, CD; van den Berg, M | 1 |
Arnesen, E; Bønaa, KH; Førde, OH; Nordrehaug, JE; Refsum, H; Ueland, PM | 1 |
Motulsky, AG | 1 |
Drown, DJ | 1 |
Angst, CP; Fowler, B; Haefeli, WE; Jordan, PP; Loehrer, FM; Ritz, R | 1 |
Delport, R; Ubbink, JB; Vermaak, WJ | 1 |
Allen, RH; Herzlich, BC; Lichstein, E; Malinow, MR; Namba, T; Nieto, FJ; Pagala, M; Ravindran, K; Schulhoff, N; Stabler, SP; Weinstock, M | 1 |
Adao, M; Azinheira, J; Bordalo, A; Ferreira, NC; Luis, AS; Pina, JE; Reis, HP; Reis, RP; Santos, L | 1 |
Racek, J; Rosolová, H; Simon, J | 1 |
Sobra, J | 1 |
Aull, S; Deecke, L; Lalouschek, W; Schnider, P; Uhl, F; Zeiler, K | 1 |
Montalescot, G | 1 |
Fleischer, L; Handler, B; Kummerow, FA; Olinescu, R | 1 |
Arveiler, D; Cambien, F; Ducimetiere, P; Evans, AE; Luc, G; Malinow, MR; Upson, BM | 1 |
Evans, A; Gallagher, PM; Graham, IM; McMaster, D; Meleady, R; Rozen, R; Shields, DC; Tan, KS; Whitehead, AS | 1 |
Superko, HR | 2 |
Bignell, M; Hanson, NQ; Schwichtenberg, K; Tsai, MY | 1 |
Pilgeram, L | 1 |
Perry, IJ | 1 |
Ankri, A; Benzidia, R; Blacher, J; Chadefaux-Vekemans, B; Grosgogeat, Y; Kamoun, P; Montalescot, G; Thomas, D | 1 |
Cheng, TO | 6 |
Sanderson, JE; Sung, JJ | 1 |
Mamotte, CD; Taylor, RR; van Bockxmeer, FM; Vasikaran, SD | 1 |
Adão, M; Azinheira, J; Bordalo-Sá, AL; Correia, JM; Luís, AS; Pina, JE; Reis, HP; Reis, RP; Santos, L | 1 |
Anker, G; Lien, EA; Lønning, PE; Refsum, H; Ueland, PM | 1 |
Allain, P; Benoit, C; Geslin, P; Le Bouil, A; Olivier, E; Tadei, A | 1 |
Christensen, B; Frosst, P; Genest, J; Goyette, P; Lussier-Cacan, S; Rosenblatt, DS; Rozen, R; Selhub, J | 1 |
Futterman, LG; Lemberg, L | 1 |
Aizawa, T; Kaneda, H; Kitaoka, M; Kurihara, H; Kurihara, Y; Maemura, K; Minamino, T; Morita, H; Ogasawara, K; Ohno, M; Shindo, T; Suzuki, S; Taguchi, J; Yamaoki, K; Yazaki, Y | 2 |
Mansoor, MA | 1 |
Anderson, PH; Block, PC; Duell, PB; Gluckman, RA; Hess, DL; Holzgang, CR; Kruger, WD; Lin, QR; Malinow, MR; Nieto, FJ; Seltzer, D; Upson, B | 1 |
Farstad, M; Nordrehaug, JE; Nygård, O; Refsum, H; Ueland, PM; Vollset, SE | 1 |
Conri, C; Gosse, P; Le Metayer, P; Mercié, P; Parrot, F | 1 |
DeRose, DJ; Mullen, K; Muscat, J | 1 |
Aljada, A; Baliga, BS; Dandona, P; Fink, L; Fonseca, VA; Munshi, M; Stone, A; Thusu, K | 1 |
Donner, MG; Richter, WO; Schwandt, P | 1 |
Bjerve, KS; Carlsen, SM; Følling, I; Grill, V; Refsum, H; Schneede, J | 1 |
Markle, HV | 1 |
Blom, HJ; Boerma, GJ; Boers, GH; Bruschke, AV; Heil, SG; Jukema, JW; Kastelein, JJ; Kluijtmans, LA; Lindemans, J; Trijbels, FJ; van den Heuvel, LP; Verheugt, FW; Willems, F | 1 |
Wang, XL; Wilcken, B; Wilcken, DE | 1 |
Ahn, C; Aronow, WS | 2 |
Bottiglieri, T; Lowenthal, D; Parnetti, L | 1 |
Frohlich, JJ; McManus, BM; Moghadasian, MH | 1 |
Baudouy, M; Candito, M; Gibelin, P; Houenassi, M; Morand, P; Van Obberghen, E | 1 |
Hopkins, PN; Hunt, SC; James, BC; Vincent, GM; Williams, RR; Wu, LL | 1 |
Moll, S | 1 |
Farhadi, D | 1 |
Assmann, G; von Eckardstein, A | 1 |
Mendall, MA; Perry, IJ; Strachan, DP; Whincup, PH | 1 |
Markus, H; Mendall, ME; Saxena, V; Swaminathan, S | 1 |
Chook, P; Sanderson, JE; Woo, KS; Young, RP | 1 |
Beresford, SA; Motulsky, AG; Omenn, GS | 1 |
Arheart, K; Boers, G; Brattström, L; Daly, L; Graham, I; Meleady, R; Palma-Reis, R; Refsum, H; Robinson, K; Rubba, P; Ueland, P; Witteman, J | 1 |
Donner, MG; Klein, GK; Mathes, PB; Richter, WO; Schwandt, P | 1 |
Rimm, EB; Stampfer, MJ; Verhoef, P | 1 |
Anderson, PH; Block, PC; Duell, PB; Gluckman, RA; Hess, DL; Kruger, WD; Malinow, MR; Phillipson, BE; Upson, BM | 1 |
Amemiya, H; Arinami, T; Fujiwara, H; Hamaguchi, H; Kawata, K; Kikuchi, S; Noguchi, Y; Ou, T; Saito, M; Sugishita, Y; Yamakawa-Kobayashi, K | 1 |
Abbate, R; Brunelli, T; Capanni, M; Fatini, C; Gensini, GF; Marcucci, R; Pepe, G; Prisco, D; Sardi, I; Simonetti, I | 1 |
Bata, I; Dempsey, G; Dunn, J; Johnstone, DE; Kirkland, SA; MacDonald, MC; Nassar, B; O'Neill, BJ; Title, LM; Zayed, E | 1 |
Brönstrup, A; Pietrzik, K | 1 |
Ambrosi, P; Barlatier, A; Bouvenot, G; Garçon, D; Habib, G; Kreitmann, B; Luccioni, R; Métras, D; Riberi, A; Rolland, PH | 1 |
Davis, CE; Eckfeldt, JH; Folsom, AR; Hess, DL; Malinow, MR; McGovern, PG; Nieto, FJ; Tsai, MY | 1 |
Bloomgarden, ZT | 1 |
Chen, J; Hunter, DJ; Kelsey, K; Rimm, EB; Stampfer, MJ; Verhoef, P; Willett, WC | 1 |
Bissé, E; Dierkes, J; Luley, C; Mayer, H; Nauck, M; Orth, M; Wieland, H | 1 |
Franco, A; Haverstick, L; Malone, M; Rothkopf, MM; Usiskin, K | 1 |
Wanner, C; Zimmermann, J | 1 |
Czeizel, E; Matos, L | 1 |
Connor, SL; Connor, WE; Gerhard, GT; Malinow, MR; Pappu, AS; Sexton, G; Wander, RC | 1 |
Mijatovic, V; Stehouwer, CD; van Baal, WM; van der Mooren, MJ | 1 |
Feskens, EJ; Jakobs, C; Kromhout, D; Stehouwer, CD; van den Berg, M; Weijenberg, MP | 1 |
Ali, A; Lavie, CJ; Li, S; Lin, HC; Lohmann, TP; Malik, FS; Mehra, MR; Milani, RV; Murgo, JP | 1 |
Daida, H; Hosoda, Y; Iwama, Y; Mokuno, H; Yamaguchi, H; Yokoi, H | 1 |
Danesh, J; Lewington, S | 1 |
Asmi, M; Busjahn, A; Joubran, R; Jouma, M; Luft, FC; Vergopoulos, A | 1 |
de Lorgeril, M; Lacan, P; Paillard, F; Richard, G; Salen, P | 1 |
Hamada, C; Kurihara, H; Kurihara, Y; Morita, H; Oh-hashi, Y; Shindo, T; Sugiyama, T; Yazaki, Y | 1 |
Bayle, C; Bellet, H; Caussé, E; Champagne, S; Couderc, F; Salvayre, R; Siri, N; Valdiguié, P | 1 |
Kluger, J | 1 |
Abou-Ghazala, T; Alsous, F; Arheart, K; Gupta, A; Jacobsen, DW; Kruger, WD; Lobo, A; Moustapha, A; Nahlawi, M; Naso, A; Robinson, K; van Lente, F | 1 |
McNamara, JR; Schaefer, EJ; Seman, LJ | 1 |
Carluccio, M; De Caterina, R; Diviacco, S; Fioretti, P; Mariani, M; Pilotto, L; Quadrifoglio, F; Vanuzzo, D | 1 |
Bignell, MK; Bullemer, FE; Graham, KJ; Hanson, NQ; Rasmussen, R; Schwichtenberg, K; Tsai, MY; Vessey, J; Welge, BG; Yang, F | 1 |
Alikaşifoğlu, M; Atalar, E; Aytemir, K; Kes, S; Ovünç, K; Ozer, N; Tokgözoğlu, SL; Tunçbilek, E; Usal, O | 1 |
Berenson, GS; Dalferes, E; Greenlund, KJ; Myers, L; Pickoff, A; Srinivasan, SR; Xu, JH | 1 |
Abel, JG; Cook, RC; Frohlich, JJ; Gao, M; Ignaszewski, AP; Kingsbury, K; Parker, S; Tupper, JK | 1 |
Assmann, G; Bobak, M; Bui, M; Fobker, M; Gostomzyk, J; Hense, HW; Junker, R; Kark, J; Kuch, B; Marmot, M; Schulte, H; Sinnreich, R; Vojtisek, P; von Eckardstein, A | 1 |
Connor, SL; Connor, WE; DeLoughery, TG; Evans, AJ; Gerhard, GT; Malinow, MR; Sexton, G; Wander, RC | 1 |
Beaulieu, AJ; Bostom, AG; Dworkin, L; Gohh, RY; Han, H; Jacques, PF; Liaugaudas, G; Rosenberg, IH; Selhub, J | 1 |
Bausserman, L; Bostom, AG; Jacques, PF; Liaugaudas, G; Rosenberg, IH; Selhub, J | 1 |
Illingworth, DR | 1 |
Adachi, T; Cai, H; Cranney, G; Duarte, N; Sim, AS; Wang, XL; Wilcken, DE | 1 |
Ebrahim, SB; Lennon, L; Morris, R; Perry, IJ; Refsum, H; Thomson, A; Ueland, PM; Walker, M; Whincup, PH | 1 |
Britten, MB; Elsner, M; Schächinger, V; Scharrer, I; Walter, DH; Zeiher, AM | 1 |
Cole, DE; Langman, LJ | 1 |
Keller, C; Pietrzik, K; Weiss, N | 1 |
Haraki, T; Inazu, A; Kajinami, K; Kawashiri, M; Koizumi, J; Mabuchi, H; Nohara, A; Takegoshi, T; Yagi, K | 1 |
Aranda, JL; Díaz-Rubio, P; Estenoz, J; Fernández-Miranda, C; Gómez de la Cámara, A; Gómez González, P | 1 |
Daniels, SR; Jacobsen, DW; Khoury, P; Morrison, JA; Robinson, K; Sprecher, DL | 1 |
Allain, P; Benoit, C; Furber, A; Geslin, P; Le Bouil, A; Merheb, M; Tadéi, A | 1 |
Cattaneo, M | 3 |
Ridker, PM | 1 |
Dudman, NP | 1 |
Tsai, MY | 1 |
Hughes, S | 1 |
McCarron, P; Smith, GD; Stone, DH | 1 |
Asmi, M; Joubran, R; Jouma, M; Law, T; Rifai, N; Spencer, A; Yu, HH | 1 |
Foody, JM; Jacobsen, DW; Milberg, JA; Pearce, GL; Robinson, K; Sprecher, DL | 1 |
Chambers, JC; Hackett, D; Hooper, J; Kooner, JS; Obeid, OA; Refsum, H; Thompson, SG; Turner, RM; Ueland, P | 1 |
Park, SC; Yoo, JH | 1 |
Bar-On, H; Ben-Yehuda, A; Friedlander, Y; Friedman, G; Kidron, M; Rosenberg, IH; Selhub, J | 1 |
Hughes, K; Ong, CN | 1 |
Bunout, D; de la Maza, P; Garrido, A; Hirsch, S; Kauffman, R; Petermann, M; Suazo, M; Venegas, P | 1 |
Bignell, M; Graham, KJ; Hanson, NQ; Tsai, MY; Welge, BG; Yang, F | 1 |
Araújo, F; Cunha-Ribeiro, LM; Gonçalves, L; Lopes, M; Maciel, MJ | 1 |
Mann, GV | 1 |
Cipriano, C; Conri, C; Constans, J; Parrot, F; Skopinski, S | 1 |
Alagratnam, D; Swaminathan, R; Turner, C; Wickramasinghe, SN; Wierzbicki, AS | 1 |
Hallegua, DS; Wallace, DJ | 1 |
Apple, FS; DiBello, PM; Holtman, V; Jacobsen, D; Ricchiuti, V; Wu, AH | 1 |
Abdelmouttaleb, I; Aimone-Gastin, I; Angioi, M; Bennani, N; Danchin, N; Gelot, MA; Guéant, JL; Jeandel, C; Lambert, D; Namour, F | 1 |
Kaplan, GA; Lakka, TA; Porkkala-Sarataho, E; Rissanen, T; Salonen, JT; Voutilainen, S | 1 |
Herzum, M; Maisch, B; Noll, B; Sattler, A; Schaefer, JR; Simon, B; Soufi, M | 1 |
Anderson, PH; Block, PC; Duell, PB; Evans, AA; Graf, EE; Hess, DL; Kruger, WD; Malinow, MR; Upson, B; Wang, L | 1 |
Bhuripunyo, K; Leowattana, W; Mahanonda, N; Pokum, S | 1 |
Calzoni, F; Carantoni, M; D'Elia, K; Fellin, R; Pareschi, PL; Passaro, A; Solini, A | 1 |
Barrera, G; Bunout, D; de la Maza, P; Hirsch, S; Kauffman, R; Petermann, M; Suazo, M | 1 |
Caidahl, K; Christensen, B; Hartford, M; Herlitz, J; Karlsson, T; Omland, T; Samuelsson, A | 1 |
Gejyo, F; Hiraoka, M; Kimura, H; Kobata, R; Mayumi, M; Nishida, K; Saito, M; Toyooka, M; Tsuchida, S; Tsukahara, H | 1 |
Brattström, L | 1 |
Baker, H; Falanagan, P; McGonigle, N; Swaney, C | 1 |
Bernhard, W; Fuchs, D; Ledochowski, M | 1 |
Raheja, BS; Talim, M | 1 |
Ghosh, P; Khan, SA | 1 |
Swaminathan, R; Wierzbicki, AS | 1 |
Booth, GL; Wang, EE | 1 |
Brattström, L; Hultberg, B; Landgren, F; Nielsen, NE; Swahn, E | 1 |
Arnett, DK; Eckfeldt, JH; Ellison, RC; Tsai, MY; Williams, RR | 1 |
Babaei, S; Banijamali, H; Bowman, KA; Chisholm, RJ; Connelly, PW; Hegele, RA; Lau, HK; Miner, SE; Sparkes, J; Strauss, BH; Teitel, JM | 1 |
Hamada, C; Kitaoka, M; Kurihara, H; Kuwaki, T; Morita, H; Nagai, R; Suzuki, S; Yazaki, Y | 1 |
Hämelahti, P; Lakka, TA; Lehtimäki, T; Poulsen, HE; Salonen, JT; Voutilainen, S | 1 |
Borkenstein, M; Erwa, W; Gallistl, S; Mangge, H; Sudi, K | 1 |
Allen, JK; Blumenthal, aR; Nass, CM; Post, WS; Wiviott, SD | 1 |
Anderson, JL; Bair, TL; Carlquist, JF; Horne, BD; Madsen, TE; Muhlestein, JB; Pearson, RR | 1 |
Cummings, PM; Genest, JJ; Giddens, K; Nassar, BA; Title, LM | 1 |
Brown, CA; Gravel, RA; Kaufman, JS; McKinney, KQ; Rozen, R | 1 |
Misra, A | 1 |
Assmann, G; Cullen, P | 1 |
Gao, W; Jiang, N; Zhu, G | 1 |
Cleophas, TJ; Hornstra, N; van der Meulen, J; van Hoogstraten, B | 1 |
Chambers, JC; Ireland, H; Kooner, JS; Lane, DA; Obeid, OA; Refsum, H; Reilly, P; Thompson, E; Ueland, P | 1 |
Arcelus, R; Blanco-Vaca, F; Camps, J; Figuera, L; Joven, J; Martorell, L; Simó, JM; Vilella, E; Virgos, C | 1 |
Chambers, JC; Kooner, JS; Obeid, OA; Refsum, H; Ueland, PM; Wrigley, J | 1 |
Landmark, K; Reikvam, A | 1 |
Graham, IM; O'Callaghan, P | 1 |
Abdella, N; Akanji, AO; Mojiminiyi, OA | 1 |
Evans, M; Oudit, GY; Taylor, BV | 1 |
Aras, O; Hanson, NQ; Tsai, MY; Yang, F | 1 |
Crook, MA; Junadi, E; Lambert-Hammill, M; Lumb, PJ; Wierzbicki, AS | 1 |
Ben-Shlomo, Y; Elwood, P; Fallon, UB; Smith, GD; Ubbink, JB | 1 |
Balcells, S; Ferrer, I; Garcia-Giralt, N; Grinberg, D; Mainou, C; Meco, JF; Ordovás, JM; Palá, M; Pintó, X; Vilaseca, MA | 1 |
Ayaori, M; Higashi, K; Hisada, T; Ishikawa, T; Ito, T; Nakajima, K; Nakamura, H; Ohsuzu, F; Saionji, K; Shige, H; Tamai, S; Yonemura, A; Yoshida, H | 1 |
Hanson, NQ; Schwichtenberg, K; Tsai, MY; Yang, F | 1 |
Maxwell, SR | 1 |
Abrams, J; Chai, AU | 1 |
Assanelli, D | 1 |
Vos, E | 1 |
Akyürek, O; Dinçer, I; Erol, C; Ertas, F; Gülec, S; Kiliçkap, M; Kumbasar, SD; Laleli, Y; Oral, D; Sipahi, E | 1 |
Baumann, G; Cascorbi, I; Gerloff, T; Laule, M; Meisel, C; Müller, JM; Roots, I; Stangl, K; Stangl, V; Wernecke, KD | 1 |
Choi, TM; Hong, SY; Hwang, KY; Kim, CH; Shin, WY | 1 |
Aras , O; Hanson, NQ; Tsai, MY; Yang, F | 1 |
Chou, ST; Huang, JL; Ko, LE; Lim, PS; Yang, CS | 1 |
Crooks, RL; Fryer, JL; Silberberg, JS; Wlodarczyk, JH | 1 |
Axenti, I; Brzostek, T; Czachór, R; Dropiński, J; Jankowski, M; Musiał, J; Sanak, M; Szczeklik, A; Tendera, M; Twardowska, M | 1 |
Bostom, AG; Jacques, PF; Liaugaudas, G; Rosenberg, IH; Selhub, J | 1 |
Alfthan, G; Aromaa, A; Heliövaara, M; Knekt, P; Marniemi, J; Reunanen, A; Rissanen, H | 2 |
Armani, U; Bertolini, S; Cerone, R; Minniti, G; Piana, A; Susco, G | 1 |
Jones, HJ; Landray, MJ; McGlynn, FJ; Thambyrajah, J; Townend, JN; Wheeler, DC | 1 |
Lavie, L; Levy, Y; Yeromenko, Y | 1 |
Doshi, SN; Goodfellow, J; Kredan, MB; Lang, D; Lewis, MJ; McDowell, IF; Moat, SJ; Newcombe, RG | 1 |
Alho, H; Jokela, H; Kalela, A; Koivu, TA; Koivula, T; Nikkari, ST; Sillanaukee, P | 1 |
Chambers, JC; Kooner, JS | 1 |
Hecht, HS; Superko, HR | 1 |
D'Agostino, RB; Jacques, PF; Meigs, JB; Nathan, DM; Rifai, N; Selhub, J; Singer, DE; Wilson, PW | 1 |
Atzmon, O; Baruch, Y; Ben-Ari, Z; Fainaru, M; Greenberg, A; Levi, N; Schafer, Z; Sulkes, J; Tur-Kaspa, R | 1 |
Baigent, C; Jones, HJ; Kendall, MJ; Landray, MJ; McGlynn, FJ; Thambyrajah, J; Townend, JN; Wheeler, DC | 1 |
Cincotta, M; O'Dea, K; Pindan, B; Rowley, KG; Skinner, K; Skinner, M; Su, Q; White, GA | 1 |
Aksoyek, S; Haznedaroglu, I; Kabakci, G; Kes, S; Kirazli, S; Oto, A; Ovunc, K; Ozmen, F; Sinici, I; Tokgozoglu, SL; Yildirir, A | 1 |
Gao, W; Jiang, N; Meng, Z; Tang, J | 1 |
Alimollah, A; Gao, SZ; Giannetti, N; Herity, NA; Hunt, SA; Schroeder, JS; Valantine, HA; Yeung, AC | 1 |
Cole, DE; Daly, PA; Evrovski, J; Miner, SE; Ross, HJ; Verma, A | 1 |
Chen, Z; Tang, J; Xu, H | 1 |
Jang, Y; Kim, OY; Lee, JH; Lee, SY; Park, HY | 1 |
Chen, J; Gao, R; Hui, R; Liu, H; Wu, Y; Zhang, C | 1 |
Bushara, K; Bushara, M; Fiore, MC; Jorenby, DE; McBride, PE; Stein, JH | 1 |
Adlercreutz, H; Kaikkonen, J; Morrow, JD; Nurmi, T; Roberts, LJ; Salonen, JT; Vanharanta, M; Voutilainen, S | 1 |
Erkelens, DW; Roeters van Lennep, JE; van der Wall, EE; Westerveld, HT | 1 |
Acevedo, M; Cross, JA; Foody, JM; Frolkis, JP; Hoogwerf, BJ; Pashkow, FJ; Pearce, GL; Robinson, K; Sprecher, DL; Vidt, DG | 1 |
Ozkan, E; Ozkan, Y; Simşek, B | 1 |
Ford, ES; Mueller, PW; Smith, SJ; Steinberg, KK; Stroup, DF; Thacker, SB | 1 |
Bickel, C; Blankenberg, S; Hofman, KP; Meyer, J; Peetz, D; Rupprecht, HJ; Tiret, L | 1 |
Andersson, A; Arnadottir, M; Hultberg, B; Jonasson, T; Ohlin, H | 1 |
Al-Attas, O; Al-Daghri, N; Al-Maatouq, M; Al-Nozah, M; Bartlett, WA; Jones, AF; Kumar, S; Martin, SC | 1 |
Bode, G; Brenner, H; Fischer, HG; Hoffmann, MM; Hoffmeister, A; Koenig, W; März, W; Rosenthal, J; Rothenbacher, D | 1 |
Battler, A; Birnbaum, Y; Magal, N; Mager, A; Shohat, M | 1 |
Clearfield, M; Cook, TJ; Downs, JR; Gotto, AM; Pradhan, AD; Ridker, PM; Shih, J; Weis, SE | 1 |
Kobayashi, K; Kouzuma, R; Miyamoto, M; Nagai, Y; Nakashima, Y; Nihei, S; Okazaki, M; Tasaki, H; Tsutsui, M; Yamashita, K | 1 |
Abreu González, P; Domínguez Rodríguez, A; Jiménez Sosa, A | 1 |
Green, R; Jagust, WJ; Miller, JW; Mungas, DM; Reed, BR | 1 |
Burke, V; Kaye, JM; McCann, VJ; Stanton, KG; Taylor, RR; van Bockxmeer, FM; Vasikaran, SD | 1 |
Jacques, PF; Kark, JD; Rosenberg, IH; Selhub, J; Sinnreich, R | 1 |
Acampa, M; Capecchi, PL; Cuomo, A; Diciolla, F; Giordano, A; Guideri, F; Laghi Pasini, F; Lazzerini, PE; Lisi, GF; Maccherini, M; Massai, MR; Toscano, M | 1 |
Knopp, RH | 1 |
Abreu González, P; Barragán Acea, A; de Armas Trujillo, D; Domínguez Rodríguez, A; García González, MJ; Jiménez Sosa, A | 1 |
Costimba, I; Delaportas, N; Georgalidis, C; Kaliolia, I; Karaliotas, G; Katsarou, A; Klonou, E; Koulouridis, E; Krokida, A; Lachanas, A; Panagiotaki, E; Tzilianos, M | 1 |
Fendrick, AM; Nallamothu, BK; Omenn, GS | 1 |
Wilcken, B; Wilcken, DE | 1 |
Berg, K | 1 |
Lewis, CA; Pancharuniti, N; Sauberlich, HE | 1 |
Berg, K; Kierulf, P; Malinow, MR; Upson, B | 1 |
Hennekens, CH; Malinow, MR; Newcomer, LM; Stampfer, MJ; Tishler, PV; Ullmann, D; Upson, B; Willett, WC | 1 |
Olszewski, AJ | 1 |
Becker, PJ; Bennett, JM; Bissbort, S; Ubbink, JB; van Staden, DA; Vermaak, WJ | 1 |
Kang, SS; Norusis, M; Ruggie, N; Sora, J; Susmano, A; Wong, PW | 1 |
Cahalane, S; Clarke, R; Daly, L; Fowler, B; Graham, I; Naughten, E; Robinson, K | 1 |
Genest, JJ; Malinow, MR; McNamara, JR; Salem, DN; Schaefer, EJ; Wilson, PW | 1 |
McCully, KS; Olszewski, AJ; Szostak, WB | 1 |
Bialkowska, M; McCully, KS; Olszewski, AJ; Rudnicki, S; Szostak, WB | 1 |
Borst, M; Deussen, A; Kroll, K; Schrader, J | 1 |
Cook, HY; Kang, SS; Messer, JV; Norusis, M; Wong, PW | 1 |
Achterberg, PW; de Jong, JW; de Tombe, PP; Harmsen, E | 1 |
86 review(s) available for homocysteine and Coronary Disease
Article | Year |
---|---|
The association between plasma homocysteine and coronary heart disease is modified by the MTHFR 677C>T polymorphism.
Topics: Aged; Angina, Unstable; Biomarkers; Case-Control Studies; Coronary Disease; Female; Genotype; Heterozygote; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Risk Factors | 2013 |
Novel metabolic biomarkers of cardiovascular disease.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adiponectin; Biomarkers; Coronary Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glycated Hemoglobin; Haptoglobins; Homocysteine; Humans; Lipoprotein(a); Lipoproteins, HDL; Vitamin D | 2014 |
An alternative pseudolikelihood method for multivariate random-effects meta-analysis.
Topics: Aryldialkylphosphatase; Computer Simulation; Coronary Disease; Homocysteine; Humans; Likelihood Functions; Male; Methylenetetrahydrofolate Reductase (NADPH2); Models, Statistical; Multivariate Analysis; Prostatic Neoplasms | 2015 |
Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective studies.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Observational Studies as Topic; Odds Ratio; Prospective Studies; Young Adult | 2015 |
Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis.
Topics: Adult; Case-Control Studies; Cohort Studies; Coronary Disease; Female; Homocysteine; Humans; Male; Odds Ratio; Prospective Studies; Risk Factors; Sex Factors | 2008 |
Hyperhomocysteinemia and sudden cardiac death: potential arrhythmogenic mechanisms.
Topics: Animals; Arrhythmias, Cardiac; Calcium Signaling; Connexins; Coronary Disease; Death, Sudden, Cardiac; Dietary Supplements; Heart; Heart Conduction System; Homocysteine; Humans; Hyperhomocysteinemia; Matrix Metalloproteinases; Myocardium; Oxidative Stress; Receptors, N-Methyl-D-Aspartate; Risk Factors; Vitamin B Complex | 2010 |
Predicting the risk of coronary heart disease. II: the role of novel molecular biomarkers and genetics in estimating risk, and the future of risk prediction.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Apolipoprotein A-I; Apolipoproteins B; Apolipoproteins E; Biomarkers; C-Reactive Protein; Coronary Disease; Cystatin C; Fibrinogen; Homocysteine; Humans; Lipoproteins; Natriuretic Peptide, Brain; Risk; Risk Assessment; Risk Factors; Uric Acid | 2010 |
Three genetic polymorphisms of homocysteine-metabolizing enzymes and risk of coronary heart disease: a meta-analysis based on 23 case-control studies.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Algorithms; Case-Control Studies; Coronary Disease; Ferredoxin-NADP Reductase; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Homocysteine; Humans; Metabolic Networks and Pathways; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Single Nucleotide; Review Literature as Topic; Risk Factors; White People | 2012 |
Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias.
Topics: Bias; Coronary Disease; Folic Acid; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Risk Factors | 2012 |
Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality.
Topics: Coronary Disease; Databases, Factual; Dietary Supplements; Homocysteine; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Vitamin B Complex | 2012 |
Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis.
Topics: Aged; Blood Glucose; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dietary Supplements; Female; Folic Acid; Glycated Hemoglobin; Homocysteine; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Vitamin B Complex | 2012 |
How progestins influence the cardiovascular effect of hormone replacement therapy.
Topics: Animals; Blood Glucose; Cardiovascular Diseases; Cardiovascular System; Coronary Disease; Estrogen Replacement Therapy; Female; Hemostasis; Homocysteine; Humans; Insulin; Lipids; Menopause; Progestins; Risk Factors | 2001 |
Effects of fibrates on serum metabolic parameters.
Topics: Anticholesteremic Agents; Carbohydrates; Cholesterol, HDL; Clinical Trials as Topic; Coronary Disease; Drug Interactions; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney; Lipoproteins; Liver; Triglycerides; Uric Acid | 2002 |
Dietary modulations in the prevention of coronary artery disease: a special emphasis on vitamins and fish oil.
Topics: alpha-Tocopherol; Animals; Antioxidants; Coronary Disease; Dietary Supplements; Fatty Acids, Unsaturated; Fish Oils; Homocysteine; Humans; Superoxide Dismutase; Vitamins | 2002 |
Targeting "hydrolytic" activity of the S-adenosyl-L-homocysteine hydrolase.
Topics: Adenosine; Adenosylhomocysteinase; Coronary Disease; Drug Design; Enzyme Inhibitors; Homocysteine; Humans; Hydrolases; Hydrolysis; Risk Factors; Structure-Activity Relationship | 2001 |
Coronary artery disease in women: a review of emerging cardiovascular risk factors.
Topics: Anticholesteremic Agents; Biomarkers; Coronary Disease; Female; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Oxidative Stress; Risk Factors; Thrombophilia; Women's Health | 2002 |
Hematological risk factors for coronary heart disease.
Topics: Antithrombins; Bacterial Infections; Coronary Disease; Factor V; Factor VIII; Fibrinogen; Homocysteine; Humans; Mutation; Plasminogen Activator Inhibitor 1; Protein C; Protein S; Prothrombin; Risk Factors | 2002 |
Hyperhomocysteinemia and transplant coronary artery disease.
Topics: Animals; Coronary Disease; Folic Acid; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Pyridoxine | 2002 |
[Helicobacterium pylori infection and coronary heart disease].
Topics: Animals; Coronary Disease; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans | 1999 |
Reducing coronary artery disease by decreasing homocysteine levels.
Topics: Coronary Disease; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Nurse's Role; Patient Education as Topic; Primary Prevention; Risk Factors; Vitamin B 12; Vitamin B 6 | 2003 |
Hyperhomocysteinemia, vascular function and atherosclerosis: effects of vitamins.
Topics: Arteriosclerosis; Avitaminosis; Coronary Disease; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Kidney Failure, Chronic; Methionine; Risk Factors; Thrombosis; Vitamin B 12 Deficiency; Vitamin B 6 Deficiency; Vitamins | 2002 |
Homocysteine and atherothrombosis: diagnosis and treatment.
Topics: Arteriosclerosis; Coronary Disease; Endothelium, Vascular; Folic Acid; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Oxidative Stress; Polymorphism, Genetic; Thrombosis | 2003 |
The nested case-control study in cardiology.
Topics: Biomarkers; Cardiology; Case-Control Studies; Coronary Disease; Homocysteine; Humans; Meta-Analysis as Topic; Prospective Studies; Risk Factors | 2003 |
[Homocysteine as a coronary risk factor].
Topics: Alcoholic Beverages; Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Diet; Female; Folic Acid; Glycine max; Homocysteine; Humans; Hyperhomocysteinemia; Male; Platelet Aggregation; Risk Factors; Vitamin B 12; Vitamin B 6 | 2003 |
Serum homocysteine and the severity of coronary artery disease.
Topics: Biomarkers; Coronary Disease; Coronary Vessels; Homocysteine; Humans | 2003 |
[Emerging risk factors for cardiovascular disease].
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Lipoprotein(a); Predictive Value of Tests; Risk Factors | 2004 |
Assessment of risk factors for coronary heart disease in vascular medicine: long-term experience and a personal view from the laboratory.
Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Homocysteine; Humans; Laboratories; Risk Assessment; Risk Factors | 2004 |
Treatment of coronary heart disease with folic acid: is there a future?
Topics: Coronary Disease; Endothelium, Vascular; Folic Acid; Hematinics; Homocysteine; Humans; Inflammation | 2004 |
Assessing coronary heart disease risk with traditional and novel risk factors.
Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Homocysteine; Humans; Lipoprotein(a); Risk Assessment; Risk Factors | 2004 |
[Fibrates: mechanism of action, effect on levels of lipids and risk of coronary events. II. Fenofibrate].
Topics: Adult; Aged; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fenofibrate; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Triglycerides | 2004 |
Is homocysteine important as risk factor for coronary heart disease?
Topics: Aging; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Prospective Studies; Risk Factors; Sex Characteristics | 2005 |
Is Hyperhomocyst(e)inemia a humoral predictor of coronary heart disease?
Topics: Clinical Trials as Topic; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Meta-Analysis as Topic; Predictive Value of Tests; Risk Factors | 2005 |
Homocysteine-lowering trials for prevention of heart disease and stroke.
Topics: Biomarkers; Clinical Trials as Topic; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Stroke; Treatment Outcome; Vitamin B Complex | 2005 |
Homocysteine and coronary heart disease.
Topics: Adult; Child; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Stroke; Vitamin B Complex; Vitamins | 2002 |
Homocysteine-lowering treatment in coronary heart disease.
Topics: Adult; Aged; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Vitamins | 2005 |
[Biomarkers in cardiology--state of the art 2007].
Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Heart Diseases; Heart Failure; Heart Valve Diseases; Homocysteine; Humans; Lipoprotein(a); Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Prognosis; Risk Assessment; Troponin | 2007 |
Polymorphism in methylentetra-hydrofolate reductase gene: important role in diseases.
Topics: Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Kidney; Methylenetetrahydrofolate Reductase (NADPH2); Models, Biological; Models, Genetic; Neoplasms; Neurodegenerative Diseases; Pharmacogenetics; Polymorphism, Genetic; Risk; Risk Factors | 2008 |
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.
Topics: Arteriosclerosis; Coronary Disease; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Pyridoxine; Risk Factors; Vitamin B 12; Vitamin B 12 Deficiency | 1995 |
Homocysteine as a risk factor for coronary artery disease.
Topics: Coronary Disease; Homocysteine; Humans; Nutritional Physiological Phenomena; Risk Factors | 1995 |
Homocysteine and vascular disease.
Topics: Cerebrovascular Disorders; Coronary Disease; Homocysteine; Humans; Peripheral Vascular Diseases; Thrombophlebitis; Vascular Diseases | 1995 |
Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Cerebrovascular Disorders; Coronary Disease; Homocysteine; Humans | 1995 |
Vitamin nutrition status and homocysteine: an atherogenic risk factor.
Topics: Arteriosclerosis; Case-Control Studies; Coronary Disease; Folic Acid; Homocysteine; Humans; Nutritional Status; Pyridoxine; Risk Factors; Vitamin B 12 | 1994 |
New directions in dietary studies of coronary heart disease.
Topics: Coronary Disease; Diet; Dietary Fats; Dietary Fiber; Homocysteine; Humans; Iron; Risk Factors; Vitamins | 1995 |
Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease.
Topics: Arteriosclerosis; Betaine; Coronary Disease; Folic Acid; Heterozygote; Homocysteine; Homocystinuria; Homozygote; Humans; Methionine; Pyridoxine; Risk Factors; Vascular Diseases | 1994 |
Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid.
Topics: Arteriosclerosis; Coronary Disease; Female; Folic Acid; Homocysteine; Homocystinuria; Humans; Male; Neural Tube Defects; Nutritional Physiological Phenomena; Polymorphism, Genetic; Risk Factors; Sex Characteristics | 1996 |
Plasma homocyst(e)ine: a risk factor for arterial occlusive diseases.
Topics: Arterial Occlusive Diseases; Cerebrovascular Disorders; Coronary Disease; Homocysteine; Humans; Risk Factors | 1996 |
Homocysteine--an atherogenic and a thrombogenic factor?
Topics: Arteriosclerosis; Clinical Trials as Topic; Coronary Disease; Female; Homocysteine; Humans; Male; Risk Factors; Thrombophlebitis | 1995 |
[Hyperhomocysteinemia].
Topics: Arteriosclerosis; Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Neural Tube Defects | 1996 |
[Hyperhomocyst(e)inemia--an independent risk factor of stroke].
Topics: Amino Acid Metabolism, Inborn Errors; Arterial Occlusive Diseases; Cerebrovascular Disorders; Coronary Disease; Homocysteine; Homocystine; Humans; Risk Factors | 1996 |
Lipid disorders contributing to coronary heart disease: an update.
Topics: Cholesterol, LDL; Clinical Trials as Topic; Coronary Angiography; Coronary Disease; Cost-Benefit Analysis; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Risk | 1996 |
Effects of hormones on the plasma levels of the atherogenic amino acid homocysteine.
Topics: Aminoglutethimide; Antineoplastic Agents, Hormonal; Arteriosclerosis; Breast Neoplasms; Cardiovascular Diseases; Cholesterol; Coronary Disease; Estrogen Antagonists; Female; Homocysteine; Humans; Male; Myocardial Infarction; Tamoxifen | 1997 |
[Homocysteine and coronary heart disease. Is slight or moderate homocysteinemia related to increased risk of coronary heart disease?].
Topics: Adult; Child; Coronary Disease; Genetic Carrier Screening; Homocysteine; Homocystinuria; Humans; Risk Factors | 1997 |
Thermolabile methylenetetrahydrofolate reductase in coronary artery disease.
Topics: Coronary Disease; Enzyme Stability; Genotype; Homocysteine; Homozygote; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oxidoreductases Acting on CH-NH Group Donors; Prevalence; Risk Factors; Temperature | 1997 |
Role of homocysteine in age-related vascular and non-vascular diseases.
Topics: Aged; Aging; Alcoholism; Central Nervous System; Cerebrovascular Disorders; Cognition; Coronary Disease; Depression; Estrogens; Female; Folic Acid Deficiency; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylation; Peripheral Vascular Diseases; Renal Replacement Therapy; Vascular Diseases; Vitamin B 12 Deficiency | 1997 |
Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background.
Topics: Clinical Medicine; Coronary Disease; Evidence-Based Medicine; Homocysteine; Humans | 1997 |
New risk factors for coronary heart disease in Asia.
Topics: Adult; Aged; Aging; Asia; Child; Cholesterol, HDL; Coronary Disease; Endothelium, Vascular; Homocysteine; Humans; Hyperlipidemias; Insulin Resistance; Middle Aged; Obesity; Risk Factors; Smoking | 1997 |
Folate and coronary heart disease.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Coronary Disease; Folic Acid; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Nutrition Policy; Oxidoreductases; Polymorphism, Genetic; Risk Factors | 1998 |
The role of homocysteine, folate and other B-vitamins in the development of atherosclerosis.
Topics: Arteriosclerosis; Coronary Disease; Folic Acid; Hematinics; Homocysteine; Humans; Middle Aged; Pyridoxine; Risk Factors; Vitamin B 12; Vitamin B Complex | 1997 |
Causes of coronary heart disease in patients on renal replacement therapy.
Topics: Animals; Apolipoproteins B; Coronary Disease; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Kidney Failure, Chronic; Lipoprotein(a); Renal Dialysis; Risk Factors | 1998 |
[The role of hyper-homocysteinemia in the etiology of some vascular diseases].
Topics: Cerebrovascular Disorders; Coronary Disease; Diet Therapy; Female; Homocysteine; Humans; Male; Peripheral Vascular Diseases; Risk Factors; Vitamin B Complex | 1998 |
Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease.
Topics: Cholesterol; Coronary Disease; Estrogen Replacement Therapy; Estrogens; Female; Homocysteine; Humans; Hypertension; Lipoprotein(a); Postmenopause; Risk Factors | 1998 |
Should all elderly people receive folate supplements?
Topics: Aged; Aging; Coronary Disease; Dietary Supplements; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Male; Neoplasms; Nutritional Requirements; Nutritional Status | 1998 |
Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies.
Topics: Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors | 1998 |
Lipoprotein(a), homocysteine, and remnantlike particles: emerging risk factors.
Topics: Biomarkers; Coronary Disease; Diet; Female; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoprotein(a); Male; Risk Factors; Triglycerides | 1999 |
[The genetic component of coronary risk. II].
Topics: Alleles; Animals; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cardiovascular Diseases; Case-Control Studies; Coronary Disease; Genotype; Homocysteine; Humans; Models, Genetic; Mutation; Plasminogen Activators; Polymorphism, Genetic; Prospective Studies; Renin-Angiotensin System; Research; Retrospective Studies; Risk Factors; Thrombosis | 1999 |
New risk factors for coronary heart disease.
Topics: Blood Coagulation Factors; C-Reactive Protein; Coronary Disease; Genotype; Homocysteine; Humans; Infections; Inflammation; Lipoprotein(a); Peptidyl-Dipeptidase A; Risk Factors | 1999 |
Homocysteine: cholesterol of the 90s?
Topics: Adult; Coronary Disease; Homocysteine; Humans; Practice Guidelines as Topic; Risk Factors; Vitamins | 1999 |
[Hyperhomocysteinemia, a risk factor for atherosclerosis: causes and effects].
Topics: Age Factors; Arterial Occlusive Diseases; Arteriosclerosis; Cerebrovascular Disorders; Coronary Disease; Cross-Sectional Studies; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Lipid Metabolism; Lipoproteins; Male; Meta-Analysis as Topic; Methionine; Middle Aged; Peripheral Vascular Diseases; Prospective Studies; Pyridoxine; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors | 1999 |
Novel risk factors and markers for coronary disease.
Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Lipoprotein(a); Risk Factors; Thrombophilia; Vasculitis | 2000 |
Moderate hyperhomocysteinemia and cardiovascular disease.
Topics: Animals; Arterial Occlusive Diseases; Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Thrombosis | 2000 |
Novel risk factors for coronary heart disease: emerging connections.
Topics: Arteriosclerosis; Coronary Disease; Hemostasis; Homocysteine; Humans; Hyperlipidemias; Inflammation; Iron; Lipoproteins; Risk Factors | 2000 |
How accelerated atherosclerosis in SLE has changed our management of the disorder.
Topics: Antibodies, Antiphospholipid; Arteriosclerosis; Coronary Disease; Homocysteine; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Risk Factors | 2000 |
Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
Topics: Aged; Arteriosclerosis; Canada; Coronary Disease; Dietary Supplements; Disease Susceptibility; Fasting; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Mass Screening; Methionine; Preventive Medicine; Pyridoxine; Randomized Controlled Trials as Topic; Risk Factors; Vitamin B 12 | 2000 |
Risk factors for atherosclerosis in young individuals.
Topics: Adolescent; Adult; Age Factors; Arteriosclerosis; Birth Weight; Blood Coagulation Factors; Child; Child, Preschool; Coronary Disease; Diabetes Complications; Exercise; Female; Homocysteine; Humans; Hypertension; Infant; Infant, Newborn; Insulin Resistance; Leptin; Life Style; Lipids; Lipoprotein(a); Male; Middle Aged; Obesity; Primary Prevention; Risk Factors; Sex Factors; Smoking | 2000 |
Homocysteine, a risk factor for coronary artery disease or not? A meta-analysis.
Topics: Biomarkers; Case-Control Studies; Comorbidity; Coronary Disease; Female; Homocysteine; Homocystinuria; Humans; Incidence; Male; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2000 |
[Nutrition, dietary supplementation and coronary heart disease].
Topics: Coronary Disease; Dietary Fats; Dietary Supplements; Feeding Behavior; Female; Fish Oils; Folic Acid; Homocysteine; Humans; Lipoproteins; Male; Nutritional Physiological Phenomena; Nuts; Phytosterols; Pyridoxine; Randomized Controlled Trials as Topic; Risk Factors; Vitamin B 12 | 2000 |
The role of folic acid in the prevention of cardiovascular disease.
Topics: Cardiovascular Diseases; Coronary Disease; Dietary Supplements; Female; Folic Acid; Homocysteine; Humans; Male; Models, Biological; Risk | 2000 |
Homocysteine, vitamins, and coronary artery disease. Comprehensive review of the literature.
Topics: Clinical Trials as Topic; Coronary Disease; Diet; Folic Acid; Homocysteine; Humans; Pyridoxine; Risk Factors; Vitamin B 12 | 2000 |
Coronary artery disease--free radical damage, antioxidant protection and the role of homocysteine.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Coronary Disease; Diet; Homocysteine; Humans; Oxidative Stress; Randomized Controlled Trials as Topic; Reactive Oxygen Species; Vitamin E | 2000 |
Homocysteine: a new cardiac risk factor?
Topics: Coronary Artery Disease; Coronary Disease; Dietary Supplements; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Models, Biological; Risk Factors | 2001 |
Hyperhomocysteinaemia and atherothrombosis.
Topics: Causality; Comorbidity; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Thrombosis | 2000 |
Homocysteine and cardiovascular risk in patients with diabetes mellitus.
Topics: Coronary Disease; Diabetes Complications; Diabetes Mellitus; Homocysteine; Humans; Hyperhomocysteinemia; Hypoglycemic Agents; Insulin; Metformin; Risk Factors; Vitamin B Complex | 2001 |
Risk factors for coronary heart disease: implications of gender.
Topics: Aged; Bacterial Infections; Biomarkers; C-Reactive Protein; Coronary Disease; Diabetes Complications; Estrogens; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Inflammation; Lipid Metabolism; Male; Middle Aged; Obesity; Psychosocial Deprivation; Risk Factors; Sex; Smoking; Triglycerides | 2002 |
Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies.
Topics: Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Confounding Factors, Epidemiologic; Coronary Disease; Homocysteine; Humans; Risk Factors | 2002 |
Risk factors for coronary artery disease in women.
Topics: C-Reactive Protein; Coronary Disease; Female; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Metabolic Syndrome; Risk Factors | 2002 |
Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia.
Topics: Coronary Disease; Dietary Supplements; Economics, Pharmaceutical; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Vitamin B 12; Vitamin B 6 | 2002 |
39 trial(s) available for homocysteine and Coronary Disease
Article | Year |
---|---|
Homocysteine levels and treatment effect in the PROspective Study of Pravastatin in the Elderly at Risk.
Topics: Aged; Aged, 80 and over; Biomarkers; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Netherlands; Pravastatin; Prospective Studies; Scotland; Survival Rate; Time Factors; Treatment Outcome | 2014 |
Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy.
Topics: Aged; Biomarkers; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Homocysteine; Humans; Hysterectomy; Inflammation; Insulin; Integrin beta3; Interleukin-6; Leukocyte Count; Matrix Metalloproteinase 9; Medroxyprogesterone; Middle Aged; Polymorphism, Genetic; Thrombosis; Triglycerides; von Willebrand Factor | 2008 |
Utility of Framingham Coronary Heart Disease Risk Score for predicting cardiac risk after stroke.
Topics: Adult; Coronary Disease; Double-Blind Method; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors; Stroke; Vitamins | 2012 |
Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women.
Topics: Blood Pressure; Cholesterol; Coronary Disease; Cross-Over Studies; Dietary Proteins; Dose-Response Relationship, Drug; Female; Homocysteine; Humans; Hyperlipidemias; Isoflavones; Lipids; Male; Middle Aged; Postmenopause; Soybean Proteins | 2002 |
Vitamin supplementation normalizes total plasma homocysteine concentration but not plasma homocysteine redox status in patients with acute coronary syndromes and hyperhomocysteinemia.
Topics: Acute Disease; Aged; Blood Pressure; Body Mass Index; Coronary Disease; Diabetic Angiopathies; Dietary Supplements; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Reference Values; Vitamins | 2002 |
Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial.
Topics: Aged; Coronary Disease; Cross-Over Studies; Dietary Supplements; Eating; Female; Homocysteine; Humans; Hyperlipidemias; Lipids; Lipoprotein(a); Lipoproteins, LDL; Lung; Male; Middle Aged; Nitric Oxide; Nuts; Prunus; Risk Factors | 2002 |
Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects.
Topics: Arteriosclerosis; Blood Flow Velocity; Cholesterol; Coronary Disease; Cross-Over Studies; Folic Acid; Forearm; Homocysteine; Humans; Male; Middle Aged; Placebos; Regional Blood Flow; Triglycerides; Vascular Resistance; Vitamin B 12 | 2002 |
Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Australia; Biomarkers; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Folic Acid; Follow-Up Studies; Hematinics; Homocysteine; Humans; Male; Middle Aged; New Zealand; Pyridines; Thiazepines; Time Factors; Treatment Outcome | 2002 |
Effects of the vasopeptidase inhibitor, omapatrilat, in 723 patients with coronary heart disease.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Endothelins; Female; Homocysteine; Humans; Male; Middle Aged; Neurotransmitter Agents; Protease Inhibitors; Pyridines; Thiazepines | 2002 |
Folate improves endothelial function in patients with coronary heart disease.
Topics: Administration, Oral; Brachial Artery; Coronary Disease; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Regional Blood Flow; Tetrahydrofolates; Vasodilation | 2003 |
Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.
Topics: Adult; Aged; Coronary Disease; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Risk; Stroke; Treatment Outcome; Vitamin B 12; Vitamin B 6 | 2004 |
Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Female; Follow-Up Studies; Homocysteine; Hormone Replacement Therapy; Humans; Middle Aged; Postmenopause; Probability; Progesterone; Reference Values; Risk Assessment; Statistics, Nonparametric; Treatment Outcome | 2004 |
Folate therapy and in-stent restenosis after coronary stenting.
Topics: Aged; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Vessels; Double-Blind Method; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Stents; Treatment Failure; Vitamin B 12; Vitamin B 6 | 2004 |
Cardiovascular risk factors in middle-aged women with subclinical hypothyroidism.
Topics: Adult; Biomarkers; Blood Pressure; C-Reactive Protein; Coronary Disease; Female; Homocysteine; Humans; Hyperlipidemias; Hypothyroidism; Middle Aged; Reference Values; Risk Factors; Severity of Illness Index; Statistics, Nonparametric; Sterols; Triglycerides | 2004 |
Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism.
Topics: Adolescent; Adult; Aged; Coronary Disease; Dietary Supplements; Drug Evaluation; Europe; Homocysteine; Homozygote; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; North America; Polymorphism, Single Nucleotide; Riboflavin | 2006 |
Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease.
Topics: Coronary Disease; Death, Sudden, Cardiac; Disease-Free Survival; Echocardiography, Stress; Female; Homocysteine; Humans; Hypercholesterolemia; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Regression Analysis; Renal Dialysis; Risk Factors; Secondary Prevention | 2006 |
Serum homocysteine and long-term risk of myocardial infarction and sudden death in patients with coronary heart disease.
Topics: Bezafibrate; Case-Control Studies; Coronary Disease; Death, Sudden, Cardiac; Female; Homocysteine; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors | 2007 |
Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women.
Topics: Aged; Biomarkers; C-Reactive Protein; Coronary Disease; Cross-Over Studies; E-Selectin; Enzyme-Linked Immunosorbent Assay; Fasting; Female; Homocysteine; Humans; Inflammation; Intercellular Adhesion Molecule-1; Isoflavones; Middle Aged; Milk Proteins; Postmenopause; Soybean Proteins; Vascular Cell Adhesion Molecule-1 | 2008 |
High dose ascorbate supplementation fails to affect plasma homocyst(e)ine levels in patients with coronary heart disease.
Topics: Ascorbic Acid; Coronary Disease; Homocysteine; Humans | 1994 |
Influence of serum lipoprotein(a) and homocyst(e)ine levels on graft patency after coronary artery bypass grafting.
Topics: Aged; Chi-Square Distribution; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Fatty Acids, Omega-3; Female; Graft Occlusion, Vascular; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Odds Ratio; Prospective Studies; Vascular Patency | 1994 |
Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease.
Topics: Adult; Coronary Disease; Cysteine; Folic Acid; Homocysteine; Humans; Hypoglycemic Agents; Male; Metformin; Methylmalonic Acid; Middle Aged; Vitamin B 12 | 1997 |
Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease.
Topics: Aged; Aged, 80 and over; Coronary Disease; Cross-Over Studies; Double-Blind Method; Edible Grain; Female; Folic Acid; Food, Fortified; Homocysteine; Homocystine; Humans; Male; Middle Aged; Nutrition Policy; Vitamins | 1998 |
Lipid-lowering drugs and homocysteine.
Topics: Amino Acids; Coronary Disease; Double-Blind Method; Fenofibrate; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Simvastatin | 1999 |
Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12.
Topics: Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Pyridoxine; Single-Blind Method; Vitamin B 12 | 1999 |
Agreement among four homocysteine assays and results in patients with coronary atherosclerosis and controls.
Topics: Arteriosclerosis; Chromatography, High Pressure Liquid; Coronary Disease; Female; Fluorescence Polarization Immunoassay; Homocysteine; Humans; Male; Middle Aged | 2000 |
Polygenic influence on plasma homocysteine: association of two prevalent mutations, the 844ins68 of cystathionine beta-synthase and A(2756)G of methionine synthase, with lowered plasma homocysteine levels.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Aged, 80 and over; Analysis of Variance; Cells, Cultured; Chromatography, High Pressure Liquid; Confidence Intervals; Coronary Disease; Cystathionine beta-Synthase; Female; Genetic Variation; Homocysteine; Humans; Leukocytes, Mononuclear; Logistic Models; Male; Middle Aged; Mutation | 2000 |
Serum homocysteine, folate and thermolabile variant of MTHFR in healthy Sri Lankans living in London.
Topics: Adult; Coronary Disease; Emigration and Immigration; Female; Folic Acid; Genetic Predisposition to Disease; Genetic Variation; Homocysteine; Humans; London; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Reference Values; Sri Lanka | 2000 |
Strategies to optimize CAD prevention in modern cardiology. The "Marburg CAD Prevention Project".
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Disease; Female; Homocysteine; Humans; Lipoprotein(a); Lipoproteins, HDL; Male; Middle Aged; Risk Factors; Triglycerides | 2000 |
Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Analysis of Variance; Coronary Disease; Cystathionine beta-Synthase; Female; Folic Acid; Genotype; Haplotypes; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Risk Factors; Treatment Outcome | 2000 |
Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease.
Topics: Aged; Analysis of Variance; C-Reactive Protein; Coronary Angiography; Coronary Disease; Female; Homocysteine; Humans; Lipids; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prognosis; Prospective Studies; Risk Factors | 2000 |
Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease.
Topics: Aged; Antioxidants; Ascorbic Acid; Blood Circulation; Coronary Disease; Double-Blind Method; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Lipids; Male; Malondialdehyde; Middle Aged; Nitroglycerin; Vasodilation; Vasodilator Agents; Vitamin B 12; Vitamin E | 2000 |
Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine.
Topics: Adult; Aged; Blood Glucose; Brachial Artery; Cholesterol; Cholesterol, HDL; Coronary Disease; Dietary Supplements; Double-Blind Method; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Nitroglycerin; Regression Analysis; Triglycerides; Ultrasonography; Vasodilator Agents; Vitamin B 12 | 2000 |
Effect of alcohol intake on the levels of plasma homocysteine in healthy males.
Topics: Adult; Alcohol Drinking; Aspartate Aminotransferases; Cholesterol, HDL; Coronary Disease; Epidemiologic Studies; Ethanol; gamma-Glutamyltransferase; Homocysteine; Humans; Male; Middle Aged; Triglycerides | 2000 |
A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease.
Topics: Aged; Coronary Disease; Double-Blind Method; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Nitrates; Nitrites; Regional Blood Flow; von Willebrand Factor | 2001 |
Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?
Topics: Animals; Biopterins; Cells, Cultured; Coronary Disease; Cross-Over Studies; Cytoplasm; Dietary Supplements; Dilatation, Pathologic; Double-Blind Method; Endothelium, Vascular; Female; Folic Acid; Hemodynamics; Homocysteine; Humans; Injections, Intra-Arterial; Male; Middle Aged; Oxidative Stress; Superoxides; Tetrahydrofolates | 2001 |
Consumption of whole grain and legume powder reduces insulin demand, lipid peroxidation, and plasma homocysteine concentrations in patients with coronary artery disease: randomized controlled clinical trial.
Topics: Area Under Curve; Blood Glucose; Carotenoids; Cholesterol, HDL; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Dinoprost; Edible Grain; F2-Isoprostanes; Fabaceae; Glucose Tolerance Test; Homocysteine; Humans; Insulin; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Powders; Risk Factors | 2001 |
Smoking cessation, but not smoking reduction, reduces plasma homocysteine levels.
Topics: Adult; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Oxidation-Reduction; Risk Factors; Smoking; Smoking Cessation | 2002 |
Homocysteine and methylenetetrahydrofolate reductase genotype: association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters.
Topics: Adult; Aged; Case-Control Studies; Coronary Angiography; Coronary Disease; Female; Genetic Markers; Genotype; Germany; Hemostasis; Homocysteine; Humans; Inflammation; Lipids; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prevalence; Risk Factors | 2002 |
Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events.
Topics: Acute Disease; Aged; Anticholesteremic Agents; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Homocysteine; Humans; Lovastatin; Male; Middle Aged; Myocardial Infarction; Risk Factors | 2002 |
360 other study(ies) available for homocysteine and Coronary Disease
Article | Year |
---|---|
[Correlation between Serum Homocysteine Level, MTHFR Gene Polymorphism and Patients with Hematological Diseases Complicated with Coronary Heart Disease].
Topics: Coronary Disease; Genotype; Hematologic Diseases; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic | 2022 |
Predictive Significance of High-Sensitivity C-Reactive Protein Combined with Homocysteine for Coronary Heart Disease in Patients with Anxiety Disorders.
Topics: Anxiety Disorders; C-Reactive Protein; Coronary Disease; Homocysteine; Humans; Interleukin-6 | 2022 |
Searching for serum biomarkers linking coronary heart disease and Helicobacter pylori infection using infrared spectroscopy and artificial neural networks.
Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Gastritis; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans; Neural Networks, Computer; Spectroscopy, Fourier Transform Infrared; Tumor Necrosis Factor-alpha | 2022 |
Genetic susceptibility, homocysteine levels, and risk of all-cause and cause-specific mortality: A prospective cohort study.
Topics: Adult; Aged; Cause of Death; Coronary Disease; Genetic Predisposition to Disease; Homocysteine; Humans; Middle Aged; Prospective Studies; Risk Factors | 2023 |
Development and Validation of a Novel Model for Predicting Coronary Heart Disease in Snoring Hypertensive Patients with Hyperhomocysteinemia.
Topics: Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Nomograms; Snoring | 2023 |
Correlations of degree of coronary artery stenosis with blood lipid, CRP, Hcy, GGT, SCD36 and fibrinogen levels in elderly patients with coronary heart disease.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; CD36 Antigens; Coronary Disease; Female; Fibrinogen; gamma-Glutamyltransferase; Homocysteine; Humans; Lipids; Male; Middle Aged | 2019 |
Identifying gene-environment interactions on the efficacy of folic acid therapy for hyperhomocysteinemia based on prediction model.
Topics: Aged; Algorithms; Coronary Disease; Female; Folic Acid; Gene-Environment Interaction; Genetic Predisposition to Disease; Homocysteine; Humans; Hyperhomocysteinemia; Logistic Models; Machine Learning; Male; Middle Aged; Models, Theoretical; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Stroke; Treatment Failure; Treatment Outcome | 2020 |
Analysis on the Expression and Prognostic Value of LncRNA FAF in Patients with Coronary Heart Disease.
Topics: C-Reactive Protein; Case-Control Studies; Coronary Disease; Female; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Prognosis; Risk Factors; RNA, Long Noncoding; Tumor Necrosis Factor-alpha | 2020 |
Levels and clinical significance of serum homocysteine (Hcy), high-density lipoprotein cholesterol (HDL-C), vaspin, and visfatin in elderly patients with different types of coronary heart disease.
Topics: Aged; Cholesterol, HDL; Coronary Angiography; Coronary Disease; Homocysteine; Humans; Nicotinamide Phosphoribosyltransferase | 2021 |
MTHFR C677T Polymorphism and Serum Homocysteine Level as Risk Factors of Coronary Heart Disease in Patients with Androgenetic Alopecia: A Case Control Study.
Topics: Adult; Alopecia; Case-Control Studies; Coronary Disease; Female; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Serum; Young Adult | 2021 |
Descriptive study of relationship between cardio-ankle vascular index and biomarkers in vascular-related diseases.
Topics: Aged; Albuminuria; Biomarkers; Blood Pressure; Coronary Disease; Diabetes Mellitus; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Vascular Stiffness | 2017 |
Early neurological deterioration during the acute phase as a predictor of long-term outcome after first-ever ischemic stroke.
Topics: Age Factors; Body Mass Index; C-Reactive Protein; China; Coronary Disease; Diabetes Complications; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Stroke | 2017 |
High-sensitivity C reactive protein and risk of cardiovascular disease in China-CVD study.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; China; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Risk Assessment; Risk Factors; Stroke | 2019 |
MicroRNA-128 confers protection against cardiac microvascular endothelial cell injury in coronary heart disease via negative regulation of IRS1.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Movement; Cell Survival; Cells, Cultured; Coronary Disease; Endothelial Cells; Endothelium, Vascular; Homocysteine; Insulin Receptor Substrate Proteins; Male; MicroRNAs; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; RNA, Small Interfering; Up-Regulation; Vascular Endothelial Growth Factor A | 2019 |
Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality.
Topics: Coronary Disease; Dietary Supplements; Homocysteine; Humans; Myocardial Infarction; Stroke; Vitamin B Complex | 2013 |
Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes.
Topics: Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Dietary Supplements; Dose-Response Relationship, Drug; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypoglycemic Agents; Japan; Male; Metformin; Middle Aged; Prevalence; Risk Factors; Severity of Illness Index; Stroke; Vitamin B 12; Vitamin B 12 Deficiency | 2013 |
Homocysteine and metabolic syndrome: from clustering to additional utility in prediction of coronary heart disease.
Topics: Adult; Biomarkers; Coronary Disease; Female; Follow-Up Studies; Homocysteine; Humans; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Risk Assessment | 2014 |
Multilocus heterozygosity and coronary heart disease: nested case-control studies in men and women.
Topics: Adiponectin; Adult; Aged; Biomarkers; Body Mass Index; Case-Control Studies; Cell Adhesion Molecules; Coronary Disease; Female; Follow-Up Studies; Genetic Loci; Genome-Wide Association Study; Health Personnel; Heterozygote; Homocysteine; Humans; Lipids; Male; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Risk Factors | 2015 |
Homocysteine, Ischemic Stroke, and Coronary Heart Disease in Hypertensive Patients: A Population-Based, Prospective Cohort Study.
Topics: Adult; Aged; Brain Ischemia; China; Cohort Studies; Coronary Disease; Female; Homocysteine; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Population Surveillance; Prospective Studies; Risk Factors; Stroke | 2015 |
[A prospective study on the association of plasma homocysteine level with stroke in hypertensive patients].
Topics: Antihypertensive Agents; Coronary Artery Disease; Coronary Disease; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hypertension; Incidence; Male; Prospective Studies; Socioeconomic Factors; Stroke | 2015 |
The associations between serum biomarkers and stenosis of the coronary arteries.
Topics: Adult; Aged; Biomarkers; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Constriction, Pathologic; Coronary Disease; Coronary Vessels; Cross-Sectional Studies; Female; Homocysteine; Humans; Male; Middle Aged; Regression Analysis; Risk Factors; Surveys and Questionnaires; Triglycerides | 2016 |
Daytime sleepiness is associated with hyperhomocysteinemia in rural area of China: A cross-sectional study.
Topics: Adult; Aged; Apnea; China; Coronary Disease; Cross-Sectional Studies; Disorders of Excessive Somnolence; Female; Homocysteine; Humans; Hyperhomocysteinemia; Logistic Models; Male; Middle Aged; Risk Factors; Sex Factors; Sleep; Snoring; Stroke; Surveys and Questionnaires | 2016 |
Lipid profile status and other related factors in patients with Hyperphenylalaninaemia.
Topics: Apolipoproteins A; Apolipoproteins B; Blood Pressure; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Cross-Sectional Studies; Female; Homocysteine; Humans; Lipids; Male; Methionine; Phenylketonurias; Risk Factors; Triglycerides; Vitamin B 12 | 2016 |
Novel cardiovascular risk factors in the elderly and their correlation with the Framingham risk score.
Topics: Aged; C-Reactive Protein; Coronary Disease; Creatinine; Cross-Sectional Studies; Female; Ferritins; Homocysteine; Humans; Lipoproteins, HDL; Male; Risk Assessment; Risk Factors; Triglycerides; Uric Acid | 2008 |
Polycystic ovary syndrome is associated with elevated plasma soluble CD40 ligand, a marker of coronary artery disease.
Topics: Adult; Amenorrhea; Biomarkers; CD40 Ligand; Coronary Disease; Female; Homocysteine; Humans; Insulin; Oligomenorrhea; Polycystic Ovary Syndrome; Reference Values; Waist-Hip Ratio; Young Adult | 2009 |
Serum folate is associated with coronary heart disease independently of homocysteine in Turkish men.
Topics: Adult; Coronary Disease; Cross-Sectional Studies; Female; Folic Acid; Homocysteine; Humans; Linear Models; Logistic Models; Male; Metabolic Syndrome; Middle Aged; Sex Factors; Turkey; Vitamin B 12 | 2008 |
Association between plasma thiols and immune activation marker neopterin in stable coronary heart disease.
Topics: Aged; Biomarkers; Coronary Angiography; Coronary Disease; Cysteine; Female; Homocysteine; Humans; Male; Middle Aged; Neopterin; Predictive Value of Tests; Sulfhydryl Compounds | 2008 |
Homocysteine: the Rubik's cube of cardiovascular risk factors.
Topics: Atherosclerosis; Biomarkers; Coronary Disease; Homocysteine; Humans; Hypercholesterolemia; Hyperhomocysteinemia; Hypertension; Inflammation Mediators; Myocardial Infarction; Platelet Activation; Research Design; Risk Assessment; Risk Factors; Smoking; Stroke; Vascular Cell Adhesion Molecule-1; Vitamin B Complex | 2008 |
Are C-reactive protein and homocysteine cardiovascular risk factors in obese children and adolescents?
Topics: Adolescent; C-Reactive Protein; Child; Child, Preschool; Coronary Disease; Female; Homocysteine; Humans; Male; Risk Factors | 2008 |
Gender-related differences in the relationship between plasma homocysteine, anthropometric and conventional biochemical coronary heart disease risk factors in middle-aged Indians.
Topics: Adult; Anthropometry; Blood Pressure; Body Mass Index; Coronary Disease; Cross-Sectional Studies; Diet, Vegetarian; Female; Homocysteine; Humans; India; Life Style; Lipids; Male; Middle Aged; Risk Factors; Sex Factors; Waist Circumference | 2009 |
[Levels of homocysteine and polymorphisms of homocysteine metabolism-related enzymes in patients with type 2 diabetes mellitus and coronary heart disease].
Topics: Adult; China; Coronary Disease; Cystathionine beta-Synthase; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic | 2009 |
Vasculopathic and thrombophilic risk factors for spontaneous preterm birth.
Topics: Adult; Case-Control Studies; Cholesterol, HDL; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Gestational Age; Homocysteine; Humans; Infant, Newborn; Placenta; Polymorphism, Single Nucleotide; Pregnancy; Pregnancy Complications, Cardiovascular; Premature Birth; Prospective Studies; Risk Factors; Stroke; Young Adult | 2009 |
Depression, homocysteine concentration, and cardiovascular events.
Topics: Biomarkers; Coronary Disease; Depression; Depressive Disorder, Major; Homocysteine; Humans; Risk Factors | 2009 |
Genetic and environmental influences on total plasma homocysteine and coronary artery disease (CAD) risk among South Indians.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Alleles; Coronary Disease; Female; Ferredoxin-NADP Reductase; Genotype; Glutamate Carboxypeptidase II; Homocysteine; Humans; India; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Risk Factors | 2009 |
Exclusion of a case-control study from meta-analysis.
Topics: Case-Control Studies; Coronary Disease; Homocysteine; Humans; Meta-Analysis as Topic; Research; Risk Factors | 2009 |
Use of serum homocysteine to predict stroke, coronary heart disease and death in ethnic Chinese. 12-year prospective cohort study.
Topics: Adult; Aged; China; Cohort Studies; Coronary Disease; Death; Homocysteine; Humans; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; ROC Curve; Stroke | 2009 |
Homocysteine level in Iranian patients with premature acute myocardial infarction.
Topics: Adult; Case-Control Studies; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Iran; Male; Middle Aged; Myocardial Infarction; Risk Factors | 2009 |
Trait anger, hostility, serum homocysteine, and recurrent cardiac events after percutaneous coronary interventions.
Topics: Aged; Anger; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Disease; Female; Homocysteine; Hostility; Humans; Lipids; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors | 2009 |
Task force: nontraditional markers add little to heart risk assessment.
Topics: Advisory Committees; American Heart Association; Ankle Brachial Index; Biomarkers; Blood Glucose; C-Reactive Protein; Carotid Arteries; Coronary Disease; Coronary Vessels; Homocysteine; Humans; Leukocyte Count; Lipoprotein(a); Practice Guidelines as Topic; Risk Assessment; Societies, Medical; United States | 2009 |
[Side effects of caffeine].
Topics: Abortion, Spontaneous; Arteries; Caffeine; Cholesterol; Coronary Disease; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Type 2; DNA Copy Number Variations; Elasticity; Esophageal Sphincter, Lower; Female; Fetal Growth Retardation; Glucose; Homocysteine; Humans; Hypertension; Insulin Resistance; Pregnancy; Risk Factors | 2009 |
Homocysteine, fibrinogen and anti-ox-LDL antibody levels as markers of atherosclerosis in prepubertal obese children.
Topics: Atherosclerosis; Autoantibodies; Biomarkers; Child; Coronary Disease; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Lipoproteins, LDL; Male; Obesity | 2009 |
C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study.
Topics: Adult; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Prevalence; Prospective Studies; Risk Assessment; Risk Factors | 2008 |
Homocysteine in angiographically proven coronary disease.
Topics: Coronary Angiography; Coronary Disease; Female; Homocysteine; Humans; Lipid A; Male | 2009 |
[Levels of homocysteine in blood serum--new coronary risk factors--in adult residents of our country. Results of the WOBASZ program].
Topics: Adult; Age Distribution; Aged; Coronary Disease; Female; Homocysteine; Humans; Male; Mass Screening; Middle Aged; Poland; Risk Factors; Sex Distribution; Young Adult | 2005 |
Mendelian randomisation: a tool for assessing causality in observational epidemiology.
Topics: Alcohol Drinking; Blood Pressure; Causality; Coronary Disease; Fibrinogen; Homocysteine; Humans; Mendelian Randomization Analysis; Molecular Epidemiology; Stroke | 2011 |
What is the role of alternative biomarkers for coronary heart disease?
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Biomarkers; C-Reactive Protein; Coronary Disease; Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors | 2011 |
Homocysteine, B vitamins, and the risk of cardiovascular disease.
Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Peripheral Vascular Diseases; Risk; Vitamin B Complex | 2011 |
Homocysteine-induced caspase-3 activation by endoplasmic reticulum stress in endothelial progenitor cells from patients with coronary heart disease and healthy donors.
Topics: Animals; Apoptosis; Blood Donors; Calcium Signaling; Caspase 3; Cell Line; Cinnamates; Coronary Disease; Endoplasmic Reticulum; Endothelial Cells; Homocysteine; HSP70 Heat-Shock Proteins; Humans; Male; Membrane Proteins; Oxidative Stress; Phosphorylation; Stem Cells; Thiourea | 2011 |
Premature coronary heart disease risk factors & reducing the CHD burden in India.
Topics: Atherosclerosis; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Homocysteine; Humans; Male; Thrombosis | 2011 |
Atherothrombotic risk factors & premature coronary heart disease in India: a case-control study.
Topics: Adult; Atherosclerosis; Blood Pressure; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Eating; Female; Fibrinogen; Homocysteine; Humans; India; Logistic Models; Male; Middle Aged; Platelet Count; Risk Factors; Smoking; Thrombosis; Triglycerides | 2011 |
Serum homocysteine and folate but not vitamin B12 are predictors of CHD mortality in older adults.
Topics: Age Factors; Aged; Aged, 80 and over; Biomarkers; Coronary Disease; Down-Regulation; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; New South Wales; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Up-Regulation; Vitamin B 12 | 2012 |
Three genetic polymorphisms of homocysteine-metabolizing enzymes and risk of coronary heart disease: appraisal of a recent meta-analysis.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Coronary Disease; Ferredoxin-NADP Reductase; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Single Nucleotide | 2012 |
Homocysteine and cardiovascular risk: the perils of reductionism in a complex system.
Topics: Animals; Coronary Disease; Dietary Supplements; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Risk; Vitamin B Complex | 2012 |
Relative importance of risk factors for coronary heart disease--the Hordaland Homocysteine study.
Topics: Adult; Age Factors; Aged; Biomarkers; Chi-Square Distribution; Cholesterol; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Middle Aged; Myocardial Infarction; Norway; Proportional Hazards Models; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Triglycerides | 2012 |
[Metabolic interactions between the hyperhomocysteinemia and angiotensin-1 converting enzyme activity in Tunisian patients with coronary heart disease].
Topics: Adult; Aged; Case-Control Studies; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Peptidyl-Dipeptidase A; Risk Factors; Tunisia | 2012 |
Reply to Fang SK--Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality.
Topics: Coronary Disease; Dietary Supplements; Homocysteine; Humans; Myocardial Infarction; Stroke; Vitamin B Complex | 2013 |
Serum homocysteine, creatinine, and glucose as predictors of the severity and extent of coronary artery disease in asymptomatic members of high-risk families.
Topics: Biomarkers; Blood Glucose; Coronary Angiography; Coronary Disease; Creatinine; Diabetes Complications; Diabetes Mellitus; Diagnosis, Computer-Assisted; Female; Genetic Predisposition to Disease; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Risk Factors | 2002 |
Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus.
Topics: Apolipoproteins; Biomarkers; Blood Glucose; Blood Pressure; C-Reactive Protein; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Homocysteine; Humans; Interleukin-6; Lipoproteins; Male; Middle Aged; Multivariate Analysis; N-Acetylneuraminic Acid; Regression Analysis; Risk Factors | 2002 |
Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
Topics: Adult; Coronary Disease; Cystathionine beta-Synthase; Female; Folic Acid; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Risk Factors; Vitamin B 12 | 2002 |
Homocysteine and vascular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Coronary Disease; Dose-Response Relationship, Drug; Folic Acid; Hematinics; Homocysteine; Humans; Pyridines; Thiazepines; Vascular Diseases | 2002 |
Lack of association between plasma homocysteine and angiographic coronary artery disease in the era of fortification of cereal grain flour with folic acid.
Topics: Adult; Aged; Coronary Angiography; Coronary Disease; Edible Grain; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Severity of Illness Index; Vitamin B 12 | 2002 |
High oxidized LDL and elevated plasma homocysteine contribute to the early reduction of myocardial flow reserve in healthy adults.
Topics: Adenosine; Adult; Autoantibodies; Biomarkers; C-Reactive Protein; Cell Adhesion Molecules; Chlamydophila Infections; Chlamydophila pneumoniae; Cholesterol; Cholesterol, HDL; Coronary Circulation; Coronary Disease; Ferritins; Homocysteine; Humans; Image Processing, Computer-Assisted; Linear Models; Lipoproteins, LDL; Male; Regional Blood Flow; Risk Factors; Smoking; Tomography, Emission-Computed; Triglycerides | 2002 |
Sustained increases of plasma homocysteine, copper, and serum ceruloplasmin after coronary artery bypass grafting.
Topics: Aged; Cardiopulmonary Bypass; Ceruloplasmin; Copper; Coronary Artery Bypass; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Minimally Invasive Surgical Procedures; Postoperative Complications; Risk Factors; Vitamin B 12 | 2002 |
Does short-term smoking cessation reduce plasma total homocysteine concentrations?
Topics: Adult; Body Mass Index; Cholesterol, HDL; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Random Allocation; Risk Factors; Smoking; Smoking Cessation | 2002 |
Plasma homocysteine in subjects with familial combined hyperlipidemia.
Topics: Adult; Apolipoproteins B; Blood Pressure; Body Mass Index; Cholesterol; Coronary Disease; Female; Homocysteine; Humans; Hyperlipidemia, Familial Combined; Insulin Resistance; Male; Middle Aged; Regression Analysis; Risk Factors | 2003 |
Hyperhomocysteinemia and vitamin B-12 deficiency are more striking in Syrians than in Germans--causes and implications.
Topics: Adult; Arabs; Cholesterol, LDL; Coronary Disease; Female; Germany; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylmalonic Acid; Middle Aged; Prevalence; Syria; Vitamin D Deficiency | 2003 |
Associations of plasma homocysteine concentration in subjects with type 2 diabetes mellitus.
Topics: Albuminuria; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Osmolar Concentration | 2002 |
Coronary heart disease mortality, plasma homocysteine, and B-vitamins: a prospective study.
Topics: Adult; Biomarkers; Case-Control Studies; Cohort Studies; Confidence Intervals; Coronary Disease; Female; Homocysteine; Humans; Incidence; Male; Middle Aged; Netherlands; Probability; Prognosis; Proportional Hazards Models; Prospective Studies; Reference Values; Risk Assessment; Sensitivity and Specificity; Survival Rate; Vitamin B Complex | 2003 |
Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects.
Topics: Biomarkers; Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Prospective Studies; Risk Factors | 2002 |
Serum levels of total homocysteine, homocysteine metabolites and of advanced glycation end-products (AGEs) in patients after renal transplantation.
Topics: Adult; Arginine; Coronary Disease; Cystathionine; Female; Glycation End Products, Advanced; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Kidney Transplantation; Logistic Models; Lysine; Male; Methylmalonic Acid; Middle Aged; Risk Factors | 2003 |
Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease.
Topics: Brain Ischemia; Case-Control Studies; Chronic Disease; Cohort Studies; Comorbidity; Coronary Disease; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Israel; Male; Matched-Pair Analysis; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Odds Ratio; Prospective Studies; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke | 2003 |
Homocysteine testing.
Topics: Coronary Disease; Female; Homocysteine; Humans; Male | 2003 |
Folate and risk of cardiovascular disease. Study results were misinterpreted.
Topics: Cardiovascular Diseases; Cohort Studies; Coronary Disease; Data Interpretation, Statistical; Folic Acid; Homocysteine; Humans; Meta-Analysis as Topic; Risk Factors | 2003 |
Serum homocysteine levels and mortality in outpatients with or without coronary artery disease: an observational study.
Topics: Aged; Cardiovascular Diseases; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Proportional Hazards Models; Risk Factors | 2003 |
The 2756A>G variant in the gene encoding methionine synthase: its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adenine; Case-Control Studies; Coronary Disease; Folic Acid; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genotype; Guanine; Homocysteine; Humans; Middle Aged; Osmolar Concentration; Risk Factors; Vitamin B 12 | 2003 |
A twin study of C-Reactive Protein compared to other risk factors for coronary heart disease.
Topics: Adult; Blood Pressure; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Coronary Disease; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Triglycerides; Twins, Monozygotic | 2003 |
Impact of subclinical hypothyroidism on serum total homocysteine concentrations, the prevalence of coronary heart disease (CHD), and CHD risk factors in the New Mexico Elder Health Survey.
Topics: Aged; Aged, 80 and over; Coronary Disease; Creatinine; Fasting; Female; Folic Acid; Health Surveys; Homocysteine; Humans; Hypothyroidism; Male; New Mexico; Prevalence; Risk Factors; Vitamin B 12 | 2003 |
Red wine prevents homocysteine-induced endothelial dysfunction in porcine coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blotting, Western; Bradykinin; Coronary Disease; Coronary Vessels; Culture Media; Culture Techniques; Endothelium, Vascular; Gene Expression; Homocysteine; Immunohistochemistry; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroprusside; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Swine; Wine | 2003 |
Effect of homocysteine-lowering therapy on vascular endothelial function and exercise performance in coronary patients with hyperhomocysteinaemia.
Topics: Aged; Analysis of Variance; Blood Flow Velocity; Brachial Artery; Coronary Angiography; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Exercise Test; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Ultrasonography; Vasodilation; Vitamin B 12; Vitamin B 6 | 2003 |
Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study.
Topics: Adult; Coronary Disease; Female; Homocysteine; Humans; Lipoproteins; Lupus Erythematosus, Systemic; Ontario; Risk; Risk Factors | 2003 |
[Homocysteine and progression of carotid atherosclerosis in patients with coronary disease].
Topics: Arteriosclerosis; Carotid Artery Diseases; Coronary Disease; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged | 2003 |
The impact of hyperhomocysteinemia as a cardiovascular risk factor in the prediction of coronary heart disease.
Topics: Aged; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors | 2003 |
Evidence suggests diabetes outcomes linked to homocysteine.
Topics: Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B Complex | 2003 |
The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins B; C-Reactive Protein; Chronic Disease; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Diseases; Lipoprotein(a); Male; Middle Aged; Risk Factors | 2004 |
Summaries for patients. Associations of newer cardiac risk factors with chronic kidney disease.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins B; C-Reactive Protein; Chronic Disease; Coronary Disease; Female; Fibrinogen; Homocysteine; Humans; Kidney Diseases; Lipoprotein(a); Male; Middle Aged; Risk Factors | 2004 |
Effect of folic acid fortification of food on homocysteine-related mortality.
Topics: Aged; Coronary Disease; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Risk Factors | 2004 |
Serum homocysteine in relation to mortality and morbidity from coronary heart disease: a 24-year follow-up of the population study of women in Gothenburg.
Topics: Adult; Coronary Disease; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Middle Aged; Morbidity; Myocardial Infarction; Prospective Studies; Risk Factors; Sweden | 2004 |
Serum total homocysteine levels, folate, and B-vitamins intake and coronary heart disease risk factors among tri-ethnic college students.
Topics: Adult; Black or African American; Coronary Disease; Female; Florida; Folic Acid; Hispanic or Latino; Homocysteine; Humans; Hyperhomocysteinemia; Lipids; Male; Risk Factors; Sex Factors; Smoking; Universities; Vitamin B 12; Vitamin B 6; White People | 2004 |
Eat right and exercise for lower homocysteine levels and less chance of heart disease.
Topics: Adult; Age Factors; Coronary Disease; Exercise; Feeding Behavior; Female; Florida; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Risk Factors; Smoking; Vitamin B 12; Vitamin B 6 | 2004 |
Association between plasma homocysteine levels and coronary artery disease: a population-based study in northern Greece.
Topics: Adult; Aged; Biomarkers; Case-Control Studies; Coronary Disease; Female; Greece; Homocysteine; Humans; Logistic Models; Male; Matched-Pair Analysis; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors | 2004 |
Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Topics: Aged; Biomarkers; Clinical Trials as Topic; Coronary Disease; Cross-Sectional Studies; Endothelium, Vascular; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Male; Middle Aged; Outcome Assessment, Health Care; P-Selectin; Platelet Activation; Risk Factors; Stroke; von Willebrand Factor | 2004 |
VISP and INVEST.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Coronary Disease; Homocysteine; Humans; Hypertension; Indoles; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Stroke; Verapamil; Vitamins | 2004 |
Elevated levels of plasma homocysteine are associated with neurotoxicity.
Topics: Aged; Biomarkers; Comorbidity; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neurotoxicity Syndromes; Probability; Risk Assessment; Sampling Studies; Sensitivity and Specificity; Statistics, Nonparametric | 2004 |
Fibrate treatment and prevalence risk of mild hyperhomocysteinaemia in clinical coronary heart disease patients.
Topics: Case-Control Studies; Coronary Disease; Creatinine; Female; Folic Acid; Genotype; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperhomocysteinemia; Hypolipidemic Agents; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Prevalence; Retrospective Studies; Vitamin B 12 | 2004 |
Prognostic value of tryptophan load test followed by serum kynurenine determination. Its comparison with pyridoxal-5-phosphate, kynurenine, homocysteine and neopterin amounts.
Topics: Biomarkers; Case-Control Studies; Coronary Disease; Homocysteine; Humans; Kynurenine; Neopterin; Prognosis; Pyridoxal Phosphate; Tryptophan | 2003 |
Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Coronary Disease; Enzyme Induction; Homocysteine; Imidazoles; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Myocardium; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Olmesartan Medoxomil; omega-N-Methylarginine; Oxidative Stress; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Superoxides; Tetrazoles; Thiazepines | 2004 |
Serum folate and homocysteine and the incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study.
Topics: Coronary Disease; Finland; Folic Acid; Homocysteine; Humans; Incidence; Lipids; Male; Middle Aged; Prospective Studies; Risk Factors | 2004 |
Serum homocysteine and endothelial dysfunction in circulatory disorders in women.
Topics: Arginine; Coronary Disease; Endothelium, Vascular; Female; Homocysteine; Humans; Hyperhomocysteinemia; Middle Aged; Myocardial Infarction; Nitric Oxide; Risk; Risk Factors | 2004 |
Increased plasma homocysteine concentrations in healthy people with hostile behavior: the ATTICA study.
Topics: Adult; Coronary Disease; Feeding Behavior; Female; Fibrinogen; Greece; Homocysteine; Hostility; Humans; Leukocyte Count; Life Style; Male; Middle Aged; Smoking | 2004 |
Association between serum homocysteine, folate and B12 concentration with coronary artery disease in Thai patients.
Topics: Coronary Disease; Cross-Sectional Studies; Female; Homocysteine; Humans; Logistic Models; Male; Seroepidemiologic Studies; Thailand; Vitamin B 12 | 2004 |
Homocysteine and cardiovascular disease: a 17-year follow-up study in Busselton.
Topics: Adult; Aged; Aged, 80 and over; Australia; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Confounding Factors, Epidemiologic; Coronary Disease; Creatinine; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Risk Factors; Sex Factors; Stroke | 2004 |
Incorporating cardiovascular disease risk stratification into clinical decision making.
Topics: Adult; C-Reactive Protein; Coronary Disease; Decision Making; Female; Homocysteine; Humans; Lipids; Male; Middle Aged; Peroxidase; Risk Assessment | 2004 |
An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization.
Topics: Confidence Intervals; Coronary Disease; Genotype; Homocysteine; Humans; Meta-Analysis as Topic; Methylenetetrahydrofolate Reductase (NADPH2); Phenotype; Random Allocation | 2004 |
Folate therapy and in-stent restenosis.
Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Restenosis; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Stents; Vitamin B 6; Vitamin B Complex | 2004 |
Hyperhomocysteinemia, enzyme polymorphism and thiobarbituric Acid reactive system in children with high coronary risk family history.
Topics: Adolescent; Carbon-Nitrogen Ligases; Case-Control Studies; Child; Child, Preschool; Coronary Disease; Female; Fluorometry; Genetic Markers; Genetic Predisposition to Disease; Homocysteine; Humans; Hyperhomocysteinemia; Male; Polymorphism, Restriction Fragment Length; Risk Factors; Thiobarbituric Acid Reactive Substances | 2004 |
Hypothyroidism and cardiovascular disease: role of new risk factors and coagulation parameters.
Topics: C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Coronary Disease; Endothelium, Vascular; Fibrinolysis; Homocysteine; Humans; Hypothyroidism; Risk Factors; Thyroid Hormones; Thyroxine; von Willebrand Diseases | 2004 |
Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
Topics: Adult; Apolipoprotein B-100; Apolipoproteins B; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Coronary Disease; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Lipids; Middle Aged; Myocardial Infarction; Postmenopause; Practice Guidelines as Topic; Risk; Single-Blind Method; Triglycerides | 2004 |
[The relationship between serum calcitonin gene-related peptide, sex hormone, homocysteine and coronary artery disease in postmenopausal women].
Topics: Adult; Aged; Calcitonin Gene-Related Peptide; Coronary Disease; Cross-Sectional Studies; Estradiol; Female; Homocysteine; Humans; Logistic Models; Middle Aged; Postmenopause; Progesterone; Risk Factors | 2004 |
Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study.
Topics: Adolescent; Adult; Arteriosclerosis; Blood Glucose; Body Mass Index; Brachial Artery; C-Reactive Protein; Cardiovascular Diseases; Carotid Artery, Common; Child; Child, Preschool; Cholesterol; Cohort Studies; Coronary Disease; Cross-Sectional Studies; Endothelium, Vascular; Female; Finland; Follow-Up Studies; Hemorheology; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Sampling Studies; Sex Factors; Smoking; Tunica Intima; Tunica Media; Ultrasonography; Vasodilation; Waist-Hip Ratio | 2004 |
Homocysteine as a risk factor for coronary heart diseases and its association with inflammatory biomarkers, lipids and dietary factors.
Topics: C-Reactive Protein; Cholesterol; Cholesterol, HDL; Coronary Disease; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Middle Aged; Receptors, Tumor Necrosis Factor; Risk Factors; Thiamine | 2004 |
Increased plasma homocysteine concentrations accelerate cardiac allograft vasculopathy.
Topics: Coronary Disease; Disease Progression; Female; Heart Transplantation; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Time Factors | 2004 |
Effect of homocysteine on plaque formation and oxidative stress in patients with acute coronary syndromes.
Topics: Acute Disease; Adult; Aged; Chemokine CCL2; Coronary Artery Disease; Coronary Disease; Female; Homocysteine; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Superoxide Dismutase | 2004 |
Methylenetetrahydrofolate reductase polymorphism associated with susceptibility to coronary heart disease in Chinese type 2 diabetic patients.
Topics: Asian People; Case-Control Studies; Coronary Disease; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Predictive Value of Tests; Risk Factors | 2005 |
Relevance of post-methionine homocysteine and lipoprotein (a) in evaluating the cardiovascular risk in young CAD patients.
Topics: Adult; Biomarkers; Blood Coagulation; Case-Control Studies; Chelating Agents; Coronary Disease; Fasting; Female; Folic Acid Deficiency; Homocysteine; Humans; Lipoprotein(a); Male; Methionine; Middle Aged; Risk; Statistics, Nonparametric; Thromboplastin; Vitamin B 12 Deficiency | 2005 |
Homocysteine in relation to C-reactive protein and low-density lipoprotein cholesterol in assessment of cardiovascular risk.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cardiovascular System; Case-Control Studies; Cholesterol, LDL; Coronary Disease; Female; Germany; Homocysteine; Humans; Male; Middle Aged; Odds Ratio; Risk; Risk Factors; Syria; Time Factors | 2004 |
[Relation between diabetes compensation, albuminuria and biochemical parameters and the results of stress myocardial SPECT in asymptomatic type 2 diabetics].
Topics: Albuminuria; C-Reactive Protein; Coronary Circulation; Coronary Disease; Diabetes Mellitus, Type 2; Exercise Test; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon; Uric Acid | 2004 |
Plasma homocysteine concentrations in Greek children are influenced by an interaction between the methylenetetrahydrofolate reductase C677T genotype and folate status.
Topics: Biomarkers; Child; Coronary Disease; Female; Folic Acid; Genotype; Greece; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Single Nucleotide; Risk Factors | 2005 |
Early determination of homocysteine levels in acute coronary syndromes, is it an independent prognostic factor?
Topics: Aged; Analysis of Variance; Biomarkers; Coronary Disease; Female; Homocysteine; Humans; Linear Models; Male; Myocardial Infarction; Prognosis; Spain; Survival Analysis | 2005 |
The relation between homocysteine and calcific aortic valve stenosis.
Topics: Age Factors; Aged; Aortic Valve Stenosis; Calcinosis; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diabetes Complications; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; Risk Factors; Smoking; Triglycerides | 2005 |
Meta-analysis of genetic studies using Mendelian randomization--a multivariate approach.
Topics: Coronary Disease; Homocysteine; Meta-Analysis as Topic; Methylenetetrahydrofolate Reductase (NADPH2); Models, Genetic; Models, Statistical; Multivariate Analysis; Polymorphism, Genetic | 2005 |
Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study.
Topics: Aged; Angina Pectoris; Angina, Unstable; Biomarkers; Cardiovascular Diseases; Coronary Disease; Early Diagnosis; Female; Follow-Up Studies; Germany; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Risk Assessment; Survival Rate | 2005 |
Plasma homocysteine predicts progression of atherosclerosis.
Topics: Adult; Aged; C-Reactive Protein; Calcinosis; Cohort Studies; Coronary Artery Disease; Coronary Disease; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Tomography, X-Ray Computed | 2005 |
Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.
Topics: Adult; Aged; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Disease; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Male; Middle Aged; Nitric Oxide Synthase; Prognosis; Retrospective Studies; Risk Factors; Smoking | 2006 |
Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease. The Women's Health Initiative Observational Study.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; Case-Control Studies; Cohort Studies; Coronary Disease; Cross-Sectional Studies; Estrogen Replacement Therapy; Female; Hemostasis; Homocysteine; Humans; Inflammation Mediators; Lipids; Middle Aged; Prospective Studies; Risk Factors; Tissue Plasminogen Activator | 2005 |
PAI-1 and homocysteine, but not lipoprotein (a) and thrombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stenting.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Disease; Factor V; Female; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Prothrombin; Recurrence; Regression Analysis; Risk Factors; Stents; Syndrome; Thrombophilia | 2006 |
A homocysteine metabolism-related dietary pattern and the risk of coronary heart disease in two independent German study populations.
Topics: Aged; Body Mass Index; Case-Control Studies; Coronary Disease; Diet; Female; Folic Acid; Germany; Homocysteine; Humans; Middle Aged; Multivariate Analysis; Risk Factors; Vitamin B 12 | 2005 |
Plasma homocysteine thiolactone adducts associated with risk of coronary heart disease.
Topics: Adult; Alleles; Aryldialkylphosphatase; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Gene Frequency; Genotype; Homocysteine; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors | 2006 |
[Effect of the supplementation of vitamins B12, B6 and folic acid on homocysteine and plasmatic lipids in patients with hyperlipoproteinemic secondary type IV].
Topics: Adult; Aged; Biomarkers; Cholesterol, HDL; Coronary Disease; Folic Acid; Homocysteine; Humans; Hyperlipoproteinemia Type IV; Lipids; Lipoproteins, LDL; Male; Middle Aged; Risk Factors; Triglycerides; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2005 |
Elevated levels of plasma homocysteine in postmenopausal women in Burkina Faso.
Topics: Adult; Aged; Aged, 80 and over; Aging; Blood Chemical Analysis; Burkina Faso; Coronary Disease; Female; Homocysteine; Humans; Menopause; Middle Aged; Sulfhydryl Compounds | 2005 |
[For coronary disease patients risky].
Topics: Adult; Clinical Trials as Topic; Coronary Disease; Dietary Supplements; Female; Folic Acid; Homocysteine; Humans; Middle Aged; Reference Values; Risk Factors; Vitamin B 6; Vitamins | 2005 |
Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome.
Topics: Adult; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Insulin Resistance; Lipoprotein(a); Male; Metabolic Syndrome; Middle Aged; Reference Values; Risk Factors; Statistics as Topic; Turkey; Vitamin B 12 | 2005 |
New and old cardiovascular risk factors: C-reactive protein, homocysteine, cysteine and von Willebrand factor increase risk, especially in smokers.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Coronary Disease; Cysteine; Enzyme-Linked Immunosorbent Assay; Female; Homocysteine; Humans; Incidence; Male; Middle Aged; Odds Ratio; Prognosis; Retrospective Studies; Risk Factors; Smoking; von Willebrand Factor | 2005 |
Plasma total homocysteine and gallstone in middle-aged Japanese men.
Topics: Alcohol Drinking; Blood Glucose; Coronary Disease; Diet; Folic Acid; Gallstones; gamma-Glutamyltransferase; Homocysteine; Humans; Japan; Lipids; Male; Middle Aged; Risk Factors; Smoking | 2005 |
Homocysteine and coronary microcirculation: is it a microvasculopathic agent?
Topics: Administration, Oral; Antioxidants; Ascorbic Acid; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Methionine | 2006 |
Elevated plasma homocysteine levels in patients with isolated coronary artery ectasia.
Topics: Biomarkers; Coronary Angiography; Coronary Disease; Dilatation, Pathologic; Enzyme-Linked Immunosorbent Assay; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors | 2006 |
Influence of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism, B vitamins and other factors on plasma homocysteine and risk of thromboembolic disease in Chinese.
Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Polymorphism, Genetic; Risk Factors; Thromboembolism; Vitamin B 12; Vitamin B 6 | 2005 |
Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors.
Topics: Adolescent; Child; Coronary Disease; Diabetes Mellitus, Type 1; Female; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Risk Factors; Vitamins | 2006 |
Association of plasma homocysteine with coronary artery calcification in different categories of coronary heart disease risk.
Topics: Aged; Calcinosis; Cohort Studies; Coronary Artery Disease; Coronary Disease; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; Risk Factors; Tomography, X-Ray Computed | 2006 |
High dietary methionine intake increases the risk of acute coronary events in middle-aged men.
Topics: Acute Disease; Adult; Cohort Studies; Coronary Disease; Diet Records; Dietary Proteins; Finland; Follow-Up Studies; Homocysteine; Humans; Male; Methionine; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors | 2006 |
Post-interventional homocysteine levels: failure as a predictive biomarker of in-stent restenosis.
Topics: Angioplasty, Balloon, Coronary; Biomarkers; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Homocysteine; Humans; Male; Middle Aged; Postoperative Care; Predictive Value of Tests; Pregnancy; Statistics, Nonparametric; Stents | 2006 |
Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly men and women in Jerusalem.
Topics: Aged; Aged, 80 and over; Blood Glucose; Body Weights and Measures; Butyrylcholinesterase; Coronary Disease; Cross-Sectional Studies; Female; Homocysteine; Humans; Israel; Life Style; Lipids; Male; Middle Aged; Multivariate Analysis; Regression Analysis; Risk Factors; Socioeconomic Factors | 2006 |
Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.
Topics: Adult; Arteries; Blood Pressure; Case-Control Studies; CD40 Antigens; Cholesterol, LDL; Coronary Disease; Elasticity; Endothelium, Vascular; Female; Homocysteine; Humans; Logistic Models; Lupus Erythematosus, Systemic; Male; Middle Aged; Multivariate Analysis; Risk Factors; Severity of Illness Index; Vascular Cell Adhesion Molecule-1 | 2006 |
Homocysteine and coronary heart disease risk in the PRIME study.
Topics: Biomarkers; Case-Control Studies; Cohort Studies; Coronary Disease; France; Homocysteine; Humans; Male; Middle Aged; Northern Ireland; Prospective Studies; Risk; Smoking | 2007 |
Homocysteine, folate and vitamin b12 in patients with coronary heart disease.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers; Chromatography, High Pressure Liquid; Coronary Disease; Creatinine; Diet; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Linear Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Vitamin B 12; Vitamin B Complex | 2006 |
[Peculiarities of atherosclerotic injury of carotid arteries in patients with coronary artery disease with hyperhomocysteinemia].
Topics: Adult; Aged; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Coronary Disease; Disease Progression; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Severity of Illness Index; Ultrasonography | 2006 |
Effects of atorvastatin on coagulation parameters and homocysteine in patients with primary hypercholesterolemia.
Topics: Adult; Aged; Atorvastatin; Biomarkers; Blood Coagulation; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Heptanoic Acids; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Pyrroles; Treatment Outcome | 2006 |
Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome.
Topics: Adult; Biomarkers; Cerebrovascular Disorders; Chelating Agents; Coronary Disease; Female; Homocysteine; Humans; Male; Metabolic Syndrome; Methionine; Middle Aged; Peripheral Vascular Diseases; Proportional Hazards Models; Risk Assessment | 2007 |
13N-ammonia rest/stress PET: folic acid improves global coronary vasoreactivity in coronary artery disease patients with normal or elevated homocysteine levels.
Topics: Aged; Ammonia; Coronary Angiography; Coronary Disease; Exercise Test; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Nitrogen Radioisotopes; Positron-Emission Tomography; Reference Values | 2006 |
[Association of paraoxonase polymorphisms and serum homocysteine thiolactone complex with coronary heart disease].
Topics: Adult; Aged; Aryldialkylphosphatase; Coronary Disease; Cysteine; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Polymorphism, Genetic | 2006 |
Is any link between inflammation and coronary artery ectasia?
Topics: Aged; Angiography; Coronary Angiography; Coronary Disease; Coronary Vessels; Female; Genotype; Heterozygote; Homocysteine; Humans; Inflammation; Male; Middle Aged; Models, Biological; Peptidyl-Dipeptidase A | 2007 |
Plasma homocysteine concentration in patients with poor or good coronary collaterals.
Topics: Adult; Aged; Case-Control Studies; Chronic Disease; Collateral Circulation; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Ischemia; Odds Ratio | 2007 |
Functional COMT Val158Met polymorphism, risk of acute coronary events and serum homocysteine: the Kuopio ischaemic heart disease risk factor study.
Topics: Adult; Catechol O-Methyltransferase; Cohort Studies; Coronary Disease; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Ischemia; Polymorphism, Genetic; Prospective Studies; Risk Factors | 2007 |
Hypothyroidism in coronary heart disease and its relation to selected risk factors.
Topics: Adult; Aged; Autoantibodies; Autoantigens; Coronary Disease; Cross-Sectional Studies; Czech Republic; Female; Homocysteine; Humans; Hypercholesterolemia; Hypothyroidism; Iodide Peroxidase; Iron-Binding Proteins; Male; Middle Aged; Odds Ratio; Prevalence; Risk Factors; Severity of Illness Index; Sex Distribution; Sex Factors; Thyrotropin; Time Factors; von Willebrand Factor | 2006 |
Study of homocysteine concentration in coronary heart disease patients and comparison of two determination methods.
Topics: Adult; Aged; Body Mass Index; Coronary Disease; Dyslipidemias; Gas Chromatography-Mass Spectrometry; Homocysteine; Humans; Immunoassay; Male; Middle Aged; Risk Factors | 2007 |
The impact of circulating total homocysteine levels on long-term cardiovascular mortality in patients with acute coronary syndromes.
Topics: Acute Disease; Biomarkers; Coronary Disease; Electrocardiography; Female; Follow-Up Studies; Greece; Homocysteine; Humans; Male; Middle Aged; Nephelometry and Turbidimetry; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Syndrome; Time Factors | 2008 |
The correlation of homocysteine-thiolactonase activity of the paraoxonase (PON1) protein with coronary heart disease status.
Topics: Adult; Aged; Animals; Aryldialkylphosphatase; Cholesterol; Coronary Disease; Genotype; Homocysteine; Humans; Lipoproteins; Male; Middle Aged; Polymorphism, Genetic; Regression Analysis; Statistics as Topic | 2006 |
Polymorphism in the methylenetetrahydrofolate reductase (C677T) gene and homocysteine levels: a comparison in Brazilian patients with coronary arterial disease, ischemic stroke and peripheral arterial obstructive disease.
Topics: Aged; Amino Acid Substitution; Arterial Occlusive Diseases; Brain Ischemia; Brazil; Comorbidity; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation, Missense; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide; Risk Factors | 2009 |
Serum total homocysteine concentrations and risk of mortality from stroke and coronary heart disease in Japanese: The JACC study.
Topics: Adult; Aged; Asian People; Coronary Disease; Female; Follow-Up Studies; Homocysteine; Humans; Japan; Male; Middle Aged; Risk; Stroke | 2008 |
Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria.
Topics: Adult; Amino Acids, Sulfur; Aminobutyrates; Coronary Disease; Diseases in Twins; Female; Heterozygote; Homocysteine; Homocystinuria; Humans; Male; Methionine; Middle Aged; Myocardial Infarction; Pregnancy; Twins, Monozygotic | 1983 |
Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study.
Topics: Adult; Aged; Cohort Studies; Coronary Disease; Fasting; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Predictive Value of Tests; Risk Factors | 1995 |
[Homocysteinemia as a risk factor for myocardial infarct--the importance of age and of the homocysteinemia levels].
Topics: Adult; Aging; Case-Control Studies; Confidence Intervals; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Risk Factors | 1995 |
Effective homocysteine metabolism may protect South African blacks against coronary heart disease.
Topics: Adult; Black People; Coronary Disease; Folic Acid; Homocysteine; Humans; Male; Methionine; South Africa; Vitamin B 12; Vitamins; White People | 1995 |
Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine.
Topics: Adolescent; Adult; Coronary Disease; Homocysteine; Humans; Male; Mathematics; Middle Aged; Models, Biological; Reference Values; Risk Factors; Vitamin B Complex | 1995 |
Higher plasma homocyst(e)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease.
Topics: Adult; Aged; Coronary Disease; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Male; Middle Aged; Pyridoxine; Regression Analysis; Risk Factors; Vitamin B 12 | 1995 |
Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate.
Topics: Adult; Chi-Square Distribution; Coronary Disease; Discriminant Analysis; Female; Folic Acid; France; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Pyridoxal Phosphate; Pyridoxine; Quebec; Regression Analysis; Risk Factors; Sex Factors; Vitamin B 12; Vitamin B Complex | 1995 |
Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients.
Topics: Aged; Analysis of Variance; Arteriosclerosis; Coronary Disease; Cystathionine; Folic Acid; Homocysteine; Humans; Hyperlipidemias; Methylmalonic Acid; Middle Aged; Pyridoxine; Risk Factors | 1995 |
Hyperhomocysteinaemia in heart transplant recipients.
Topics: Aged; Coronary Angiography; Coronary Disease; Fasting; Female; Heart Transplantation; Homocysteine; Humans; Male; Methionine; Middle Aged; Postoperative Complications; Renal Insufficiency | 1994 |
Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men.
Topics: Adult; Age Factors; Blood Viscosity; Coronary Disease; Fibrinogen; Homocysteine; Humans; Lipoproteins; Male; Middle Aged; Risk Factors | 1994 |
Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease.
Topics: Adult; Case-Control Studies; Coronary Disease; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Vitamin B 12 | 1994 |
Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease.
Topics: Adult; Age Factors; Aged; Cholesterol, LDL; Coronary Disease; Creatinine; Female; Homocysteine; Humans; Lipids; Male; Middle Aged; Reference Values; Regression Analysis; Risk Factors; Smoking; Uric Acid; Vitamins | 1994 |
The case that hyperhomocysteinemia is a risk factor for coronary artery disease.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Coronary Disease; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Risk Factors | 1994 |
Hyperhomocysteinaemia: a metabolic risk factor for coronary heart disease determined by both genetic and environmental influences?
Topics: Adult; Coronary Disease; Female; Gene Frequency; Homocysteine; Homocystinuria; Humans; Male; Middle Aged; Prevalence | 1993 |
Elevations in total plasma homocysteine in premature coronary artery, cerebrovascular and peripheral vascular disease.
Topics: Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Vascular Diseases | 1993 |
Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adolescent; Adult; Aged; Betaine-Homocysteine S-Methyltransferase; Cerebrovascular Disorders; Coronary Disease; Cystathionine beta-Synthase; Female; Homocysteine; Humans; Male; Methionine; Methyltransferases; Middle Aged; Peripheral Vascular Diseases; Vitamins | 1993 |
Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease.
Topics: Adult; Arteriosclerosis; Cerebrovascular Disorders; Coronary Disease; Fasting; Female; Folic Acid; Homocysteine; Humans; Leg; Male; Methionine; Middle Aged; Pyridoxine; Risk Factors; Vitamin B 12 | 1996 |
Serum total homocysteine and coronary heart disease.
Topics: Adolescent; Adult; Case-Control Studies; Child; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Norway; Prospective Studies; Regression Analysis; Risk Factors | 1995 |
Homocysteine: an independent risk factor associated with coronary disease and other arterial occlusive diseases in adults.
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Risk Factors | 1995 |
Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Case-Control Studies; Cohort Studies; Coronary Disease; Erythrocytes; Female; Follow-Up Studies; Homocysteine; Humans; Isoenzymes; Lymphocytes; Male; Methionine Adenosyltransferase; Methylation; Middle Aged; Risk Factors; S-Adenosylmethionine; Tetrahydrofolates | 1996 |
Plasma homocysteine concentrations in a population with a low coronary heart disease prevalence.
Topics: Adult; Black People; Coronary Disease; Homocysteine; Humans; Male; Prevalence; South Africa; White People | 1996 |
Relationship among homocyst(e)ine, vitamin B-12 and cardiac disease in the elderly: association between vitamin B-12 deficiency and decreased left ventricular ejection fraction.
Topics: Aged; Animals; Coronary Disease; Female; Homocysteine; Humans; Male; Rats; Stroke Volume; Ventricular Function, Left; Vitamin B 12 Deficiency | 1996 |
Homocysteinaemia after methionine overload as a coronary artery disease risk factor: importance of age and homocysteine levels.
Topics: Age Factors; Case-Control Studies; Coronary Disease; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Odds Ratio; Risk Factors | 1995 |
[Homocysteine, a less well-known risk factor in cardiac and vascular diseases].
Topics: Arteriosclerosis; Cardiovascular Diseases; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors | 1996 |
Should metformin be used to improve blood lipid pattern in nondiabetic patients with coronary heart disease?
Topics: Coronary Disease; Homocysteine; Humans; Hypoglycemic Agents; Lipids; Metformin; Risk Factors | 1996 |
Homocysteine: the new player in the field of coronary risk.
Topics: Coronary Disease; Folic Acid; Homocysteine; Humans; Risk Factors; Vitamin B Complex | 1996 |
The hemolytic activity of homocysteine is increased by the activated polymorphonuclear leukocytes.
Topics: Coronary Disease; Erythrocytes; Glutathione; Hemolysis; Homocysteine; Humans; In Vitro Techniques; Kinetics; Luminescent Measurements; Neutrophils; Reference Values | 1996 |
Plasma homocyst(e)ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease.
Topics: Adult; Alcohol Drinking; Apolipoprotein A-I; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Comorbidity; Coronary Disease; France; Homocysteine; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Northern Ireland; Obesity; Odds Ratio; Risk; Risk Factors; Smoking; Survivors | 1996 |
Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation.
Topics: Alanine; Alleles; Coronary Disease; DNA Mutational Analysis; Female; Gene Frequency; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Risk Factors; Temperature; Valine | 1996 |
High prevalence of a mutation in the cystathionine beta-synthase gene.
Topics: Adult; Coronary Disease; Cystathionine beta-Synthase; DNA Mutational Analysis; Female; Homocysteine; Humans; Male; Middle Aged; Mutagenesis, Insertional; Polymerase Chain Reaction | 1996 |
Perspective: a mechanism underlying homocysteinemia and increased risk of coronary artery and cerebrovascular disease.
Topics: Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Risk Factors | 1996 |
Serum total homocysteine concentration and risk of stroke.
Topics: Cardiovascular Diseases; Case-Control Studies; Coronary Disease; Homocysteine; Humans; Male; Odds Ratio; Risk Factors; United Kingdom | 1996 |
[Hyperhomocysteinemia in coronary artery diseases. Apropos of a study on 102 patients].
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Coronary Disease; Female; Folic Acid; France; Hematinics; Homocysteine; Humans; Male; Middle Aged; Prevalence; Risk Factors; Severity of Illness Index | 1996 |
Hyperhomocysteinaemia and the heart.
Topics: Coronary Disease; Homocysteine; Humans; Risk Factors | 1996 |
Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease.
Topics: Chronic Disease; Coronary Disease; Endothelium, Vascular; Gastritis; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans; Intestinal Absorption; Nutritional Status; Vitamin B Deficiency | 1996 |
Methylenetetrahydrofolate reductase gene and coronary artery disease.
Topics: Adult; Case-Control Studies; Coronary Disease; Female; Folic Acid; Genotype; Homocysteine; Homozygote; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Random Allocation; Risk Factors | 1997 |
[Basal homocysteinemia or following a methionine load. Which is the better indicator of coronary disease risk?].
Topics: Case-Control Studies; Coronary Disease; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Odds Ratio; Risk Factors; Time Factors | 1996 |
Elevated high-density lipoprotein cholesterol, not protective in the presence of homocysteinemia.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Cholesterol, HDL; Coronary Disease; Female; Homocysteine; Humans; Intermittent Claudication; Risk Factors | 1997 |
[Moderate hyper-homocysteinemia and coronary involvement].
Topics: Coronary Disease; Homocysteine; Humans; Middle Aged | 1996 |
Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease.
Topics: Adult; Coronary Disease; Female; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors | 1997 |
Homocysteine and coronary artery disease.
Topics: Adult; Coronary Disease; Folic Acid; Homocysteine; Homocystinuria; Humans; Male; Risk Factors | 1997 |
Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adult; Aged; Aged, 80 and over; Alleles; Asian People; Canada; Comorbidity; Coronary Disease; Disease Susceptibility; Gene Frequency; Genotype; Homocysteine; Humans; Japan; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases; Point Mutation; Polymorphism, Genetic; Risk Factors; White People | 1997 |
Hyperhomocysteinaemia and premature coronary artery disease in the Chinese.
Topics: Asian People; Coronary Disease; Homocysteine; Humans; Vitamin B 6 Deficiency | 1997 |
Homocysteinaemia and coronary atherosclerosis.
Topics: Asian People; Coronary Disease; Cystathionine beta-Synthase; Homocysteine; Humans | 1997 |
The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.
Topics: Alleles; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Regression Analysis; Risk Factors; Vitamins | 1997 |
[Gene Polymorphism of 5, 10-methylenetetrahydrofolate reductase as a coronary risk factor].
Topics: Adult; Asian People; Coronary Disease; Homocysteine; Humans; Japan; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Risk Factors | 1997 |
Plasma homocysteine levels and mortality in patients with coronary artery disease.
Topics: Adult; Aged; Cause of Death; Coronary Angiography; Coronary Disease; Creatinine; Female; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke Volume; Survival Analysis | 1997 |
[Homocysteine in case of coronary disease].
Topics: Adult; Coronary Disease; Female; Homocysteine; Humans; Male; Risk Factors | 1997 |
Expanding and understanding risk factors for coronary heart disease.
Topics: Coronary Disease; Homocysteine; Humans; Life Style; Risk Factors | 1997 |
Another cause of hyperhomocysteinemia.
Topics: Arteriosclerosis; Coronary Disease; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans | 1997 |
Hyperhomocysteinemia is a risk factor for coronary artery disease even in the presence of elevated high-density lipoprotein cholesterol.
Topics: Cholesterol, HDL; Coronary Disease; Homocysteine; Humans; Risk Factors | 1997 |
Oxidative stress in diabetic macrovascular disease: does homocysteine play a role?
Topics: Adult; Analysis of Variance; Brain Ischemia; Carotid Artery Diseases; Case-Control Studies; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Free Radicals; Homocysteine; Humans; Hypoglycemic Agents; Insulin; Lipid Peroxidation; Male; Methionine; Middle Aged; Oxidative Stress; Peripheral Vascular Diseases; Sulfonylurea Compounds; Thiobarbiturates | 1997 |
Coronary artery disease associated with Helicobacter pylori infection is at least partially due to inadequate folate status.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Biological Availability; Coronary Disease; Folic Acid; Folic Acid Deficiency; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans; Intestinal Absorption; Models, Biological | 1997 |
Methylenetetrahydrofolate reductase (MTHFR) mutation, homocyst(e)ine, and coronary artery disease.
Topics: Adult; Coronary Disease; Homocysteine; Homocystine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Prospective Studies | 1997 |
Association between plasma homocysteine and coronary artery disease in older persons.
Topics: Age Factors; Aged; Aged, 80 and over; Coronary Disease; Cross-Sectional Studies; Female; Folic Acid; Homocysteine; Humans; Logistic Models; Male; Prevalence; Sex Factors; Vitamin B 12 | 1997 |
Hyperhomocysteinaemia.
Topics: Coronary Disease; Homocysteine; Humans; Risk Factors; Smoking | 1997 |
[Blood levels of homocysteine in patients under 55 years of age with acute coronary insufficiency].
Topics: Acute Disease; Adult; Coronary Disease; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Reproducibility of Results; Risk Factors | 1997 |
Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease.
Topics: Age of Onset; Aged; Bilirubin; Case-Control Studies; Cholesterol, HDL; Comorbidity; Coronary Disease; Diabetes Mellitus; Female; Homocysteine; Humans; Hypertension; Lipids; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Odds Ratio; Risk Factors; Smoking; Survivors; Utah | 1997 |
Plasma homocysteine levels and mortality in patients with coronary artery disease.
Topics: Coronary Disease; Homocysteine; Humans; Risk Factors | 1997 |
Plasma homocysteine levels and mortality in patients with coronary artery disease.
Topics: Coronary Disease; Folic Acid; Homocysteine; Humans; Risk Factors | 1997 |
Plasma homocysteine levels and mortality in patients with coronary artery disease.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Blood Proteins; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors | 1997 |
Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease.
Topics: Coronary Disease; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans; Risk; Risk Factors | 1997 |
Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease.
Topics: Coronary Disease; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans; Risk; Risk Factors | 1997 |
Preventing coronary heart disease: B vitamins and homocysteine.
Topics: Cerebrovascular Disorders; Coronary Disease; Folic Acid; Homocysteine; Humans; Peripheral Vascular Diseases; Pyridoxine; Vitamins | 1998 |
Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.
Topics: Adult; Analysis of Variance; Arteriosclerosis; Avitaminosis; Case-Control Studies; Cerebrovascular Disorders; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Multicenter Studies as Topic; Peripheral Vascular Diseases; Pyridoxine; Risk Factors; Vascular Diseases; Vitamins | 1998 |
Plasma total homocysteine levels in patients with early-onset coronary heart disease and a low cardiovascular risk profile.
Topics: Adult; Body Constitution; Body Mass Index; Cholesterol, HDL; Coronary Disease; Cysteine; Female; Fibrinogen; Glutathione; Homocysteine; Humans; Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Risk Factors; Sex Characteristics; Triglycerides; Uric Acid | 1998 |
Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study.
Topics: Adult; Aged; Alleles; Apolipoprotein E4; Apolipoproteins E; Case-Control Studies; Coronary Disease; Data Interpretation, Statistical; Demography; Female; Genotype; Homocysteine; Humans; Japan; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Risk Factors | 1998 |
The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD).
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Comorbidity; Coronary Disease; Diabetes Mellitus; Disease Susceptibility; DNA Mutational Analysis; Female; Gene Frequency; Genotype; Homocysteine; Hot Temperature; Humans; Hyperlipidemias; Hypertension; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Obesity; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymerase Chain Reaction; Prevalence; Protein Denaturation; Recurrence; Risk Factors; Smoking | 1998 |
Relation of a common mutation in methylenetetrahydrofolate reductase to plasma homocysteine and early onset coronary artery disease.
Topics: Age of Onset; Aged; Autoanalysis; Chromatography, High Pressure Liquid; Coronary Disease; Disease Susceptibility; Genetic Variation; Genotype; Heterozygote; Homocysteine; Homozygote; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation | 1998 |
Association of mild hyperhomocysteinemia with cardiac graft vascular disease.
Topics: Adult; Case-Control Studies; Coronary Disease; Heart Transplantation; Homocysteine; Humans; Middle Aged; Risk Factors | 1998 |
Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.
Topics: Arteriosclerosis; Cohort Studies; Coronary Disease; Dietary Supplements; Fasting; Female; Folic Acid; Homocysteine; Humans; Incidence; Male; Middle Aged; Polymorphism, Genetic; Prospective Studies; Pyridoxal Phosphate; Risk Factors; Vitamin B 12 | 1998 |
International Diabetes Federation Meeting, 1997, and other recent meetings. Atherosclerosis and related topics.
Topics: Antioxidants; Arteriosclerosis; Coronary Disease; Diabetes Mellitus; Diabetic Angiopathies; Homocysteine; Humans; Risk Factors | 1998 |
A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: results among U.S. men.
Topics: Adult; Aged; Alleles; Case-Control Studies; Confidence Intervals; Coronary Disease; Diet; Folic Acid; Follow-Up Studies; Genotype; Heterozygote; Homocysteine; Homozygote; Humans; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Pyridoxine; Riboflavin; Risk Factors; Smoking; United States; Vitamin B 12 | 1998 |
The diagnostic value of serum homocysteine concentration as a risk factor for coronary artery disease.
Topics: Coronary Disease; Demography; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Life Style; Lipids; Lipoproteins; Male; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors; ROC Curve; Surveys and Questionnaires; Vitamin B 12 | 1998 |
Improvement of coronary artery disease in a patient with hyperhomocysteinemia: report of a case.
Topics: Adult; Angiography; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia | 1998 |
Premenopausal black women have more risk factors for coronary heart disease than white women.
Topics: Adolescent; Adult; Black or African American; Black People; Blood Pressure; Body Mass Index; Coronary Disease; Diet; Educational Status; Female; Homocysteine; Humans; Incidence; Least-Squares Analysis; Lipoproteins; Middle Aged; Oregon; Premenopause; Risk Factors; White People | 1998 |
Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cerebrovascular Disorders; Coronary Disease; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Risk | 1998 |
Modulatory impact of cardiac rehabilitation on hyperhomocysteinemia in patients with coronary artery disease and "normal" lipid levels.
Topics: Aged; Coronary Disease; Exercise; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Treatment Outcome | 1998 |
[Elevated levels of plasma homocysteine related to saphenous vein graft disease after coronary artery bypass graft surgery].
Topics: Aged; Coronary Artery Bypass; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Regression Analysis; Risk Factors; Saphenous Vein; Vascular Patency | 1998 |
Homocysteine levels and coronary heart disease in Syria.
Topics: Adult; Aged; Case-Control Studies; Coronary Angiography; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Syria | 1998 |
Polymorphism of the methionine synthase gene : association with homocysteine metabolism and late-onset vascular diseases in the Japanese population.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Age of Onset; Aged; Asian People; Brain Ischemia; Cerebrovascular Disorders; Coronary Disease; Female; Gene Frequency; Homocysteine; Humans; Japan; Male; Middle Aged; Mutation; Polymorphism, Genetic | 1999 |
Plasma homocysteine determined by capillary electrophoresis with laser-induced fluorescence detection.
Topics: Coronary Disease; Electrophoresis, Capillary; Fluorescence; Homocysteine; Humans; Lasers; Reproducibility of Results; Venous Thrombosis | 1999 |
Beyond cholesterol.
Topics: Cholesterol; Coronary Disease; Feeding Behavior; Homocysteine; Humans; Norway; Risk Factors; United States; Vegetables | 1997 |
Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Age of Onset; Coronary Disease; Cystathionine beta-Synthase; Fasting; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymorphism, Genetic | 1999 |
Methylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate.
Topics: Case-Control Studies; Cholesterol; Coronary Disease; Folic Acid; Genotype; Homocysteine; Humans; Lipoproteins, HDL; Methylenetetrahydrofolate Dehydrogenase (NADP); Odds Ratio; Polymerase Chain Reaction; Regression Analysis; Risk; Turkey; Vitamin B 12 | 1999 |
Plasma homocysteine distribution and its association with parental history of coronary artery disease in black and white children: the Bogalusa Heart Study.
Topics: Adolescent; Adult; Age Factors; Biomarkers; Black People; Blood Pressure; Body Mass Index; Child; Child, Preschool; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Coronary Disease; Female; Homocysteine; Humans; Louisiana; Male; Parents; Risk Factors; Sex Characteristics; Skinfold Thickness; Triglycerides; White People | 1999 |
Effect of immunosuppressive therapy, serum creatinine, and time after transplant on plasma total homocysteine in patients following heart transplantation.
Topics: Adolescent; Adult; Aged; Cerebrovascular Disorders; Coronary Disease; Creatinine; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Immunosuppressive Agents; Male; Middle Aged; Prevalence; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome | 1999 |
An ecological study of determinants of coronary heart disease rates: a comparison of Czech, Bavarian and Israeli men.
Topics: Aged; Blood Glucose; Blood Pressure; Coronary Disease; Czechoslovakia; Fibrinogen; Germany; Homocysteine; Humans; Israel; Lipoproteins; Male; Middle Aged; Prevalence; Risk Factors; Triglycerides | 1999 |
Higher total homocysteine concentrations and lower folate concentrations in premenopausal black women than in premenopausal white women.
Topics: Adolescent; Adult; Black People; Coronary Disease; Feeding Behavior; Female; Folic Acid; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Premenopause; Reference Values; Surveys and Questionnaires; Vitamin B 12; White People | 1999 |
Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery disease patients after fortification of cereal grain flour with folic acid.
Topics: Coronary Disease; Fasting; Female; Flour; Folic Acid; Food, Fortified; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Transplantation; Male; Middle Aged; Vitamin B 12 | 1999 |
Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine.
Topics: Adult; Aged; Coronary Disease; Creatinine; Cystatin C; Cystatins; Fasting; Female; Homocysteine; Humans; Kidney; Male; Middle Aged; Predictive Value of Tests; Reference Values | 1999 |
Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Age Distribution; Aged; Analysis of Variance; Australia; Coronary Disease; Cystathionine beta-Synthase; Female; Homocysteine; Hospitals; Humans; Incidence; Logistic Models; Male; Middle Aged; Oxidative Stress; Polymorphism, Genetic; Population Surveillance; Risk Factors; Severity of Illness Index; Sex Distribution | 1999 |
Homocysteine and coronary artery disease.
Topics: Biomarkers; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Pteroylpolyglutamic Acids; Risk Factors; Severity of Illness Index | 1999 |
Serum total homocysteine and coronary heart disease: prospective study in middle aged men.
Topics: Adult; Age Factors; Biomarkers; Case-Control Studies; Coronary Disease; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Prognosis; Prospective Studies; Risk Factors | 1999 |
A positive family history of premature coronary artery disease is associated with impaired endothelium-dependent coronary blood flow regulation.
Topics: Adult; Aged; Coronary Circulation; Coronary Disease; Endothelium, Vascular; Exercise Test; Female; Genotype; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Peptidyl-Dipeptidase A; Risk Factors | 1999 |
Plasma homocysteine level and development of coronary artery disease.
Topics: Adult; Age of Onset; Aged; Coronary Artery Disease; Coronary Disease; Homocysteine; Humans; Lipids; Male; Middle Aged; Prospective Studies; Risk Factors; Severity of Illness Index | 1999 |
[Hyperhomocysteinemia is frequent in coronary disease patients. Study of 202 patients].
Topics: Aged; Case-Control Studies; Confidence Intervals; Coronary Disease; Creatinine; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Odds Ratio | 1999 |
Serum glutathione in adolescent males predicts parental coronary heart disease.
Topics: Adolescent; Aged; Anthropometry; Blood Pressure; Case-Control Studies; Cohort Studies; Coronary Artery Disease; Coronary Disease; Glutathione; Homocysteine; Humans; Lipids; Logistic Models; Male; Middle Aged; Ohio; Oxidation-Reduction; Oxidative Stress; Parents; Sulfhydryl Compounds | 1999 |
[Plasma homocysteine is not a predictive factor of restenosis after coronary angioplasty].
Topics: Aged; Angioplasty, Balloon; Biomarkers; Coronary Artery Disease; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Recurrence | 1999 |
Homocysteine and cardiovascular diseases.
Topics: Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Male; Risk Factors | 1999 |
An alternative view of homocysteine.
Topics: Arterial Occlusive Diseases; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Myocardial Infarction; Risk Factors | 1999 |
Similarities in the epidemiology of neural tube defects and coronary heart disease: is homocysteine the missing link?
Topics: Coronary Disease; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Ireland; Male; Neural Tube Defects; Public Health; United Kingdom | 1999 |
Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women.
Topics: Adult; Aged; Coronary Disease; Cross-Sectional Studies; Female; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Odds Ratio; Risk Factors | 2000 |
Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men.
Topics: Case-Control Studies; Coronary Disease; Europe; Fasting; Folic Acid; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; India; Male; Middle Aged; Risk Factors; United Kingdom; Vitamin B 12 | 2000 |
Low plasma folate in combination with the 677 C-->T methylenetetrahydrofolate reductase polymorphism is associated with increased risk of coronary artery disease in Koreans.
Topics: Adult; Aged; Asian People; Cardiac Catheterization; Coronary Disease; Female; Folic Acid; Gene Frequency; Homocysteine; Humans; Hyperhomocysteinemia; Korea; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation, Missense; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Risk Factors; Sex Factors; Vitamin B 12 | 2000 |
Plasma total homocysteine levels in subjects with hyperinsulinemia.
Topics: Adult; Aged; Blood Glucose; Coronary Disease; Cross-Sectional Studies; Female; Folic Acid; Glucose Tolerance Test; Homocysteine; Humans; Hyperhomocysteinemia; Hyperinsulinism; Insulin; Insulin Resistance; Life Style; Linear Models; Male; Middle Aged; Risk Factors | 2000 |
Homocysteine, folate, vitamin B12, and cardiovascular risk in Indians, Malays, and Chinese in Singapore.
Topics: Adult; Aged; Biomarkers; China; Coronary Disease; Cross-Sectional Studies; Disease Susceptibility; Female; Homocysteine; Humans; India; Malaysia; Male; Middle Aged; Sex Factors; Singapore; Vitamin B 12 | 2000 |
Effects of supplementation with folic acid and antioxidant vitamins on homocysteine levels and LDL oxidation in coronary patients.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Coronary Disease; Dietary Supplements; Folic Acid; Homocysteine; Humans; Lipid Peroxidation; Lipids; Lipoproteins, LDL; Vitamin B 12; Vitamin E; Vitamins | 2000 |
Hyperhomocysteinemia, MTHFR C677T genotype and low folate levels: a risk combination for acute coronary disease in a Portuguese population.
Topics: Adult; Case-Control Studies; Coronary Disease; Female; Folic Acid; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Portugal | 2000 |
The homocysteine question.
Topics: Coronary Disease; Cystine; Homocysteine; Homocystinuria; Humans | 2000 |
[Homocysteinemia: role in vascular disease].
Topics: Cerebral Infarction; Coronary Disease; Homocysteine; Humans; Risk Factors; Vascular Diseases | 2000 |
Multicenter analytical evaluation of an automated immunoassay for total plasma homocysteine.
Topics: Chemistry, Clinical; Chromatography, High Pressure Liquid; Coronary Disease; Evaluation Studies as Topic; Homocysteine; Humans; Immunoassay; Reference Values; Regression Analysis; Sensitivity and Specificity | 2000 |
Homocysteine, vitamins B6, B12, folate, and risk of coronary artery disease in patients undergoing diagnostic coronary angiography.
Topics: Aged; Case-Control Studies; Coronary Angiography; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Pyridoxine; Risk Factors; Vitamin B 12 | 2000 |
Low serum folate concentrations are associated with an excess incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study.
Topics: Adult; Cardiovascular Diseases; Carotenoids; Cohort Studies; Coronary Disease; Finland; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Lycopene; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors | 2000 |
Association between serum homocysteine, vitamin B12, folate and Thai coronary artery disease patients.
Topics: Aged; Analysis of Variance; Biomarkers; Case-Control Studies; Coronary Disease; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Homocysteine; Humans; Male; Middle Aged; Pteroylpolyglutamic Acids; Reference Values; Sensitivity and Specificity; Thailand; Vitamin B 12 | 2000 |
Factors influencing plasma homocysteine levels in type 2 diabetes.
Topics: Albuminuria; Blood Pressure; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Homocysteine; Humans; Male; Reference Values; Regression Analysis; Triglycerides; Vitamins | 2000 |
Low serum folate but normal homocysteine levels in patients with atherosclerotic vascular disease and matched healthy controls.
Topics: Aged; Arteriosclerosis; Cholesterol; Chromatography, High Pressure Liquid; Coronary Disease; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Lipoproteins, HDL; Male; Middle Aged; Risk Factors; Triglycerides; Vitamin B 12; Vitamin E | 2000 |
Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes.
Topics: Acute Disease; Aged; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Patient Admission; Predictive Value of Tests; Prognosis; Prospective Studies; Risk; Survival Analysis; Sweden | 2000 |
Methylenetetrahydrofolate reductase polymorphism in Kawasaki disease.
Topics: Case-Control Studies; Child; Child, Preschool; Coronary Aneurysm; Coronary Disease; Female; Genotype; Homocysteine; Humans; Infant; Male; Methylenetetrahydrofolate Dehydrogenase (NADP); Mucocutaneous Lymph Node Syndrome; Mutation, Missense; Polymerase Chain Reaction; Polymorphism, Genetic; Sex Factors | 2000 |
Homocysteine and heart disease in Indian Asians.
Topics: Coronary Disease; Folic Acid; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; India; Risk Factors; United Kingdom; Vitamin B 12 | 2000 |
Homocysteine and heart disease in Indian Asians.
Topics: Coronary Disease; Europe; Homocysteine; Humans; India; Male; Risk Factors; Sex Factors; Social Class; United Kingdom | 2000 |
Homocysteine and heart disease in Indian Asians.
Topics: Coronary Disease; Folic Acid; Folic Acid Deficiency; Fructose; Homocysteine; Humans; Hyperhomocysteinemia; India; Malabsorption Syndromes; United Kingdom; Vitamin B 12 | 2000 |
Homocysteine and heart disease in Indian Asians.
Topics: Coronary Disease; Diabetes Complications; Diet; Dietary Fats, Unsaturated; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Homocysteine; Humans; India; Insulin Resistance; Risk Factors; United Kingdom; Urban Health | 2000 |
Coronary heart disease in Indian Asians.
Topics: Coronary Disease; Cross-Cultural Comparison; Cross-Sectional Studies; Developing Countries; Homocysteine; Humans; Incidence; India; Poverty; United Kingdom | 2000 |
Coronary heart disease in Indian Asians.
Topics: Coronary Disease; Cross-Cultural Comparison; Developing Countries; Diet, Vegetarian; Homocysteine; Humans; India; Risk Factors; United Kingdom | 2000 |
Increased plasma homocysteine is an independent predictor of new coronary events in older persons.
Topics: Aged; Aged, 80 and over; Coronary Disease; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Risk Factors; Vitamin B 12 | 2000 |
Plasma total homocysteine levels in postmenopausal women with unstable coronary artery disease.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Female; Homocysteine; Humans; Middle Aged; Odds Ratio; Postmenopause; Reference Values; Risk Factors; ROC Curve | 2000 |
Plasma homocysteine and its association with carotid intimal-medial wall thickness and prevalent coronary heart disease: NHLBI Family Heart Study.
Topics: Aged; Carotid Arteries; Coronary Disease; Fasting; Female; Homocysteine; Humans; Male; Middle Aged; Tunica Intima; Tunica Media; Ultrasonography | 2000 |
Homocysteine, lipoprotein(a), and restenosis after percutaneous transluminal coronary angioplasty: a prospective study.
Topics: Adult; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Female; Homocysteine; Humans; Lipoprotein(a); Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Prospective Studies; Recurrence; Risk Factors | 2000 |
Homocysteine as a risk factor for restenosis after coronary angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Comorbidity; Coronary Angiography; Coronary Disease; Diabetes Mellitus; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Male; Middle Aged; Obesity; Recurrence; Risk Factors; Sensitivity and Specificity; Smoking | 2000 |
Plasma total homocysteine concentration and the risk of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study.
Topics: Adult; Analysis of Variance; Case-Control Studies; Confounding Factors, Epidemiologic; Coronary Disease; Finland; Homocysteine; Humans; Incidence; Male; Middle Aged; Prospective Studies; Regression Analysis; Risk Factors | 2000 |
Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescents.
Topics: Adolescent; Blood Pressure; Child; Child, Preschool; Cholesterol; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Insulin; Lipoproteins; Male; Methylenetetrahydrofolate Reductase (NADPH2); Obesity; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Regression Analysis; Risk Factors; Triglycerides; Vitamin B 12 | 2000 |
Global risk assessment for lipid therapy to prevent coronary heart disease.
Topics: Blood Flow Velocity; Carotid Arteries; Coronary Disease; Exercise Test; Gemfibrozil; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Risk Assessment; Risk Factors; Tunica Intima | 2000 |
A common polymorphism in methionine synthase reductase increases risk of premature coronary artery disease.
Topics: Age Factors; Base Sequence; Coronary Disease; Data Interpretation, Statistical; Female; Ferredoxin-NADP Reductase; Flavoproteins; Folic Acid; Genotype; Homocysteine; Humans; Male; Middle Aged; Molecular Sequence Data; Multivariate Analysis; Polymerase Chain Reaction; Polymorphism, Genetic; Regression Analysis; Risk; Sex Factors; Vitamin B 12 | 2000 |
Primary prevention of coronary heart disease: from controversy to consensus.
Topics: Algorithms; Biomarkers; Coronary Disease; Diagnostic Imaging; Homocysteine; Humans; Metabolism, Inborn Errors; Risk Factors | 2000 |
[The mechanisms of hyperhomocysteinemia in coronary heart disease].
Topics: Adult; Aged; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Myocardial Infarction; Risk Factors | 1998 |
Methylenetetrahydrofolate reductase 677 C-->T mutation and coronary heart disease risk in UK Indian Asians.
Topics: Adult; Alleles; Case-Control Studies; Coronary Disease; Genotype; Homocysteine; Humans; India; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Risk Factors; United Kingdom | 2000 |
Homocyst(e)ine and the C677T mutation of methylenetetrahydrofolate reductase in survivors of premature myocardial infarction.
Topics: Adult; Cholesterol; Coronary Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Myocardial Infarction; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Triglycerides | 2000 |
Homocysteine and endogenous markers of renal function in type 2 diabetic patients without coronary heart disease.
Topics: Albuminuria; Biomarkers; Blood Pressure; Coronary Disease; Creatinine; Cystatin C; Cystatins; Cysteine Proteinase Inhibitors; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Homocysteine; Humans; Kidney Function Tests; Male; Middle Aged | 2000 |
Influence of 699C-->T and 1080C-->T polymorphisms of the cystathionine beta-synthase gene on plasma homocysteine levels.
Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Cystathionine beta-Synthase; Fasting; Female; Genotype; Homocysteine; Humans; Male; Methionine; Middle Aged; Point Mutation; Polymorphism, Genetic | 2000 |
Differing relationships of methylene tetrahydrofolate reductase genotypes with cardiovascular risk in familial and polygenic hypercholesterolaemia.
Topics: Adult; Aged; Coronary Disease; Female; Genotype; Homocysteine; Humans; Hypercholesterolemia; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multifactorial Inheritance; Oxidoreductases Acting on CH-NH Group Donors; Risk Factors | 2000 |
Homocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow up.
Topics: Biomarkers; Case-Control Studies; Coronary Disease; Diet; Follow-Up Studies; Homocysteine; Humans; Linear Models; Lipids; Male; Middle Aged; Prospective Studies; Risk Factors; Smoking | 2001 |
Homocysteine and the MTHFR 677C-->T allele in premature coronary artery disease. Case control and family studies.
Topics: Adult; Age of Onset; Case-Control Studies; Coronary Disease; Family Health; Gene Frequency; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Risk Factors | 2001 |
Variable number tandem repeat in exon/intron border of the cystathionine beta-synthase gene: a single nucleotide substitution in the second repeat prevents multiple alternate splicing.
Topics: Adolescent; Adult; Aged; Alternative Splicing; Coronary Disease; Cystathionine beta-Synthase; Exons; Female; Gene Frequency; Homocysteine; Humans; Introns; Male; Middle Aged; Minisatellite Repeats; Polymorphism, Genetic | 2000 |
[Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease].
Topics: Aged; Coronary Disease; Female; Follow-Up Studies; Homocysteine; Humans; Male; Predictive Value of Tests; Risk Factors | 2001 |
Multivitamin supplements are effective and inexpensive agents to lower homocysteine levels.
Topics: Coronary Disease; Dietary Supplements; Homocysteine; Humans; Treatment Outcome; Vitamins | 2001 |
Hyperhomocysteinemia and restenosis.
Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Logistic Models; Male; Middle Aged; Odds Ratio; Recurrence; Risk Factors; Stents | 2001 |
Identification of six methylenetetrahydrofolate reductase (MTHFR) genotypes resulting from common polymorphisms: impact on plasma homocysteine levels and development of coronary artery disease.
Topics: Coronary Disease; Gene Frequency; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic | 2001 |
The methylenetetrahydrofolate reductase gene polymorphism in Koreans with coronary artery disease.
Topics: Aged; Asian People; Coronary Disease; Female; Genotype; Homocysteine; Humans; Korea; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Phenotype; Polymorphism, Genetic | 2001 |
C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.
Topics: Adult; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Coronary Disease; Fasting; Female; Fluorometry; Genotype; Homocysteine; Humans; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prevalence; Venous Thrombosis | 2001 |
Effect of age and sex on plasma total homocysteine in Taiwanese subjects.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Renal Dialysis; Risk Factors; Sex Distribution; Taiwan; Uremia | 2000 |
Association between plasma folate and coronary disease independent of homocysteine.
Topics: Case-Control Studies; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Risk Factors | 2001 |
Mutation A1298C of methylenetetrahydrofolate reductase: risk for early coronary disease not associated with hyperhomocysteinemia.
Topics: Adolescent; Adult; Age of Onset; Alleles; Case-Control Studies; Coronary Disease; Female; Folic Acid; Gene Frequency; Genetic Predisposition to Disease; Genotype; Homocysteine; Homozygote; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prevalence; Risk Factors | 2001 |
Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour.
Topics: Adult; Aged; Coronary Artery Disease; Coronary Disease; Creatinine; Edible Grain; Female; Flour; Folic Acid; Food, Fortified; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Renal Insufficiency; Risk Factors; Vitamin B 12 | 2001 |
Homocysteine and major coronary events: a prospective population study amongst women.
Topics: Adult; Case-Control Studies; Coronary Disease; Female; Finland; Homocysteine; Humans; Population Surveillance; Prospective Studies; Risk Factors | 2001 |
Screening for hyperhomocysteinemia in young adults with premature coronary artery disease.
Topics: Age of Onset; Chromatography, High Pressure Liquid; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors | 1999 |
Hyperhomocystinemia: a risk factor or a consequence of coronary heart disease?
Topics: Case-Control Studies; Cholesterol; Confounding Factors, Epidemiologic; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Logistic Models; Male; Middle Aged; Prospective Studies; Risk Factors; Surveys and Questionnaires | 2001 |
Serum homocysteine does not associate with uncomplicated coronary heart disease.
Topics: Aged; Angina Pectoris; Coronary Disease; Finland; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Regression Analysis; Risk Factors | 2001 |
Homocysteine: a novel risk factor for coronary heart disease in UK Indian Asians.
Topics: Biomarkers; Coronary Disease; Homocysteine; Humans; India; Risk Factors; United Kingdom | 2001 |
Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification.
Topics: Calcium; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Homocysteine; Humans; Lipoprotein(a); Lipoproteins, LDL; Male; Metabolic Diseases; Middle Aged; Risk Factors; Tomography, X-Ray Computed | 2001 |
Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Albuminuria; Blood Glucose; Coronary Disease; Creatinine; Fasting; Female; Folic Acid; Glucose Tolerance Test; Homocysteine; Humans; Insulin; Insulin Resistance; Male; Massachusetts; Middle Aged; Risk Factors; Sex Factors; Vitamin B 12 | 2001 |
Basal and post-methionine serum homocysteine and lipoprotein abnormalities in patients with chronic liver disease.
Topics: Aged; Apolipoproteins B; Case-Control Studies; Cholesterol; Chronic Disease; Coronary Disease; Female; Homocysteine; Humans; Lipoprotein(a); Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Liver Cirrhosis, Biliary; Liver Diseases; Methionine; Middle Aged; Risk Factors; Triglycerides | 2001 |
Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol, HDL; Cohort Studies; Coronary Disease; Creatinine; Cross-Sectional Studies; Diabetes Mellitus; Female; Hemoglobin A; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Nutritional Status; Peripheral Vascular Diseases; Prevalence; Prospective Studies | 2001 |
Improvements in circulating cholesterol, antioxidants, and homocysteine after dietary intervention in an Australian Aboriginal community.
Topics: Adolescent; Adult; Age Distribution; Analysis of Variance; Antioxidants; Australia; Cholesterol; Community Health Services; Coronary Disease; Diet; Female; Homocysteine; Humans; Life Style; Male; Native Hawaiian or Other Pacific Islander; Risk Factors; Sex Distribution | 2001 |
Extent of coronary atherosclerosis and homocysteine affect endothelial markers.
Topics: Angina, Unstable; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Coronary Disease; E-Selectin; Endothelium, Vascular; Female; Homocysteine; Humans; Male; Middle Aged; Vascular Cell Adhesion Molecule-1 | 2001 |
Hyperhomocysteinemia and hyperlipidemia in coronary heart disease.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adult; Aged; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases; Point Mutation; Risk Factors; Vitamin B 12 | 1999 |
Mild hyperhomocysteinemia is not associated with cardiac allograft coronary disease.
Topics: Adult; Aged; Coronary Angiography; Coronary Disease; Creatinine; Cross-Sectional Studies; Female; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Linear Models; Male; Middle Aged; Vitamin B 12; Vitamin B 6 | 2001 |
Hyperhomocysteinemia and transplant coronary artery disease in cardiac transplant recipients.
Topics: Adult; Coronary Angiography; Coronary Disease; Female; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Logistic Models; Male; Middle Aged | 2001 |
[Genetic polymorphisms of homocysteine metabolism related enzymes in patients with coronary heart disease].
Topics: Adult; Coronary Disease; Cystathionine beta-Synthase; Female; Gene Frequency; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length | 1999 |
Is hyperhomocysteinemia a risk factor or a consequence of coronary heart disease?
Topics: Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors | 2001 |
[The association between plasma homocysteine and the number of coronary artery with stenosis].
Topics: Coronary Disease; Female; Homocysteine; Humans; Male; Risk Factors; Sex Factors | 1999 |
Association between low serum enterolactone and increased plasma F2-isoprostanes, a measure of lipid peroxidation.
Topics: 4-Butyrolactone; Coronary Disease; Estrogens; F2-Isoprostanes; Homocysteine; Humans; Lignans; Lipid Peroxidation; Male; Middle Aged; Multivariate Analysis; Risk Factors | 2002 |
Relation of homocysteine, vitamin B(12), and folate to coronary in-stent restenosis.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Risk Factors; Stents; Vitamin B 12 | 2002 |
Blood glucose concentrations < or = 125 mg/dl and coronary heart disease risk.
Topics: Adult; Aged; Blood Glucose; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Prediabetic State; Risk Factors | 2002 |
Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease.
Topics: Aged; Case-Control Studies; Coronary Disease; Cysteine; Dipeptides; Female; Folic Acid; Homocysteine; Humans; Lipoproteins, VLDL; Male; Middle Aged; Risk Factors; Triglycerides; Vitamin B 12 | 2002 |
[Homocysteine, methylenetetrahydrofolate reductase/C677T genotype and risk for coronary heart disease. The AtheroGene study].
Topics: Case-Control Studies; Coronary Disease; Female; Folic Acid; Genotype; Germany; Homocysteine; Humans; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prevalence; Risk Factors; Vitamin B 12 | 2002 |
Renal function exerts only a minor influence on high plasma homocysteine concentrations in patients with acute coronary syndromes.
Topics: Acute Disease; Case-Control Studies; Coronary Disease; Cystatin C; Cystatins; Glomerular Filtration Rate; Homocysteine; Humans; Kidney; Vitamins | 2002 |
Serum homocysteine concentration is related to diabetes mellitus, but not to coronary heart disease, in Saudi Arabians.
Topics: Adolescent; Adult; Arteriosclerosis; Biomarkers; Body Mass Index; Child; Cholesterol; Chromatography, High Pressure Liquid; Coronary Disease; Diabetes Mellitus; Diabetic Angiopathies; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Saudi Arabia; Triglycerides | 2002 |
Plasma homocysteine, methylenetetrahydrofolate reductase genotypes, and age at onset of symptoms of myocardial ischemia.
Topics: Adult; Age of Onset; Case-Control Studies; Coronary Disease; Female; Homocysteine; Homozygote; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Risk Factors | 2002 |
Plasma level of homocysteine is inversely-associated with the development of collateral circulation in patients with single-vessel coronary artery disease.
Topics: Adult; Aged; Biomarkers; Collateral Circulation; Coronary Disease; Coronary Stenosis; Creatinine; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Smoking | 2002 |
[Homocysteine and coronary artery disease].
Topics: Coronary Disease; Homocysteine; Humans; Risk Factors | 2002 |
Homocysteine, vitamin B6, and vascular disease in AD patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Angina Pectoris; Brain Infarction; Coronary Disease; Female; Heart Failure; Homocysteine; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Odds Ratio; Pyridoxal Phosphate; Stroke; Vascular Diseases; Vitamin B 6 | 2002 |
Homocysteine, folate, methylene tetrahydrofolate reductase genotype and vascular morbidity in diabetic subjects.
Topics: Adult; Aged; Analysis of Variance; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocytes; Female; Folic Acid; Genotype; Homocysteine; Humans; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Stroke | 2002 |
Plasma homocysteine and parental myocardial infarction in young adults in Jerusalem.
Topics: Adolescent; Adult; Case-Control Studies; Cholesterol; Coronary Disease; Family Health; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Israel; Male; Myocardial Infarction; Risk Factors; United States | 2002 |
Early and delayed increase in plasma homocysteine levels in heart transplanted patients.
Topics: Analysis of Variance; Biomarkers; Cardiomyopathy, Dilated; Cholesterol; Coronary Disease; Creatinine; Female; Follow-Up Studies; Heart Transplantation; Homocysteine; Humans; Male; Middle Aged; Postoperative Period; Regression Analysis; Retrospective Studies; Risk Factors; Time Factors; Triglycerides | 2002 |
[Plasma homocysteine levels in Spanish patients with coronary artery disease].
Topics: Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Spain | 2002 |
Homocysteine and C-reactive protein levels in haemodialysis patients.
Topics: Adult; C-Reactive Protein; Case-Control Studies; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Vitamin B 12 | 2001 |
The pathogenesis of coronary artery disease. A possible role for methionine metabolism.
Topics: Coronary Disease; Cystine; Heterozygote; Homocysteine; Homocystinuria; Humans; Male; Methionine; Middle Aged | 1976 |
Molecular genetics and genetic epidemiology of cardiovascular diseases and diabetes. Introductory remarks: risk factor levels and variability.
Topics: Aged; Aged, 80 and over; Apolipoproteins; Arteriosclerosis; Carrier Proteins; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol Esters; Chromosome Mapping; Coronary Disease; Diabetes Mellitus; Genes; Genetic Variation; Glycoproteins; Homocysteine; Humans; Lipoprotein(a); Lipoproteins, HDL; Polymorphism, Genetic; Receptors, LDL; Risk Factors; Triglycerides | 1992 |
Plasma folate adequacy as determined by homocysteine level.
Topics: Adult; Arterial Occlusive Diseases; Biological Assay; Biomarkers; Chromatography, High Pressure Liquid; Coronary Disease; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Reference Values | 1992 |
Population variation and genetics of plasma homocyst(e)ine level.
Topics: Adult; Analysis of Variance; Apolipoproteins; Coronary Disease; Female; Fibrinogen; Homocysteine; Homocystine; Humans; Lipids; Male; Middle Aged; Norway; Twins; Twins, Dizygotic; Twins, Monozygotic | 1992 |
A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Coronary Disease; Homocysteine; Homocystinuria; Humans; Male; Middle Aged; Myocardial Infarction; Physicians; Prospective Studies; Regression Analysis; Risk Factors; United States | 1992 |
Homocysteine content of plasma in ischemic heart disease, the reducing effect of pyridoxine, folate, cobalamin, choline, riboflavin and troxerutin. Correction of a calculation error.
Topics: Amino Acids; Anticoagulants; Choline; Coronary Disease; Folic Acid; Homocysteine; Humans; Hydroxyethylrutoside; Pyridoxine; Riboflavin; Vitamin B 12 | 1991 |
The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease.
Topics: Adult; Cholesterol; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Disease; Homocysteine; Humans; Hypercholesterolemia; Male; Middle Aged; Risk Factors | 1991 |
Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Coronary Disease; Enzyme Activation; Female; Gene Frequency; Genes, Recessive; Genetic Carrier Screening; Genetic Variation; Homocysteine; Hot Temperature; Humans; Lymphocytes; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Risk Factors | 1991 |
Hyperhomocysteinemia: an independent risk factor for vascular disease.
Topics: Cerebrovascular Disorders; Coronary Disease; Cystathionine beta-Synthase; Female; Heterozygote; Homocysteine; Humans; Male; Methionine; Middle Aged; Odds Ratio; Risk Factors; Vascular Diseases | 1991 |
Plasma homocyst(e)ine levels in men with premature coronary artery disease.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Disease; Homocysteine; Homocystinuria; Humans; Male; Middle Aged; Reference Values; Risk Factors | 1990 |
Plasma glucosamine and galactosamine in ischemic heart disease.
Topics: Adult; Arteriosclerosis; Cholesterol; Chromatography, Ion Exchange; Coronary Disease; Galactosamine; Glucosamine; Glycoproteins; Glycosaminoglycans; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Reference Values | 1990 |
Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in atherosclerosis.
Topics: Adult; Anticoagulants; Choline; Coronary Artery Disease; Coronary Disease; Drug Therapy, Combination; Folic Acid; Homocysteine; Humans; Hydroxyethylrutoside; Lipids; Male; Middle Aged; Pyridoxine; Riboflavin; Vitamin B 12 | 1989 |
Formation of S-adenosylhomocysteine in the heart. II: A sensitive index for regional myocardial underperfusion.
Topics: Adenosine; Adenosylhomocysteinase; Animals; Coronary Circulation; Coronary Disease; Dogs; Endocardium; Homocysteine; Hydrogen-Ion Concentration; Hydrolases; Myocardium; Perfusion; S-Adenosylhomocysteine | 1988 |
Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease.
Topics: Adult; Age Factors; Aged; Blood Proteins; Coronary Disease; Female; Homocysteine; Homocystine; Humans; Male; Menopause; Middle Aged; Protein Binding; Risk; Sex Factors | 1986 |
Myocardial S-adenosylhomocysteine hydrolase is important for adenosine production during normoxia.
Topics: Adenosine; Adenosylhomocysteinase; Animals; Coronary Disease; Homocysteine; Hydrolases; In Vitro Techniques; Kinetics; Male; Myocardium; Perfusion; Rats; Rats, Inbred Strains | 1985 |